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Abstract 
Oct-4 is a member of the POU family of transcriptional regulators the majority of which 
are expressed during embryonic development and are involved in the regulation of cell 
fate decisions (Ryan et al. 1997). Previous research has demonstrated that Oct-4 is 
absolutely required for the maintenance of pluripotency, both in vivo and in vitro 
(Nichols et al. 1998; Niwa et al. 2000). Oct-4 is expressed by the pluripotent cells of the 
early embryo, and, it is also expressed during specification and development of the 
germ cell lineage and in developing oocytes (Yeom etal. 1996). 
This project is concerned with investigating the consequence of inactivating Oct-4 
during germ cell lineage specification/development and oogenesis using a Cre-loxP 
approach. To address this issue it is imperative that the Cre-loxP systems employed 
cause deletion of the foxed Oct-4 target gene in a spatially and temporally predicted 
manner with a high efficiency. To achieve targeted inactivation in primordial genu 
cells, the TNAP-Cre line was used (Lomei et al. 2000). Adult mice that were expected 
to lack Oct-4 in their germ cells were fertile and E12.5 embryos had no overt defects in 
germ cell numbers in their genital ridges. Pups born from these animals exhibited a 
mosaic pattern of inheritance of the recombined/non-recombined allele indicating that 
Crc mediated deletion occurred post fertilisation in these pups and not as a result of 
deletion in the germ cells. No pups were born that could be attributed to originate 
from an Oct-4 null germ cell. Furthermore and unexpectedly, using dormant reporter 
lines ectopic TNAP-Cre activity was detected in preimplantation embryos as opposed 
to being confined to the germ cells later during development. To achieve targeted 
inactivation in oocytes during oogenesis, the ZP3-Cre line was employed (Lewandoski 
et al. 1997). ZP3-Cre mediated deletion was found to be specifically confined to 
developing oocytes and was detectable in primary oocytes onwards. Unexpectedly, 
pups born from females that theoretically lacked Oct-4 in their oocytes always inherited 
the recombined Oct-4 allele in a Mendelian fashion. This suggests that recombination 
at the floxed Oct-4 locus had occurred in the oocyte or possibly in the single cell 
embryo, raising the possibility that Oct-4 is not required in oocytes. 
The complications that have arisen in using the TNAP-Cre expression line have 
detracted from addressing the original question of the role of Oct-4 in germ cells. 
FurthenTnore, since no reporter gene was activated on recombination at the floxed Oct-4 
locus, the assessment of Cre activity relied on the activation of silent reporters which 
may not have necessarily reflected the activity at the foxed Oct-4 locus. Mosaic ectopic 
TNAP-Cre mediated deletion in the early embryo is likely to account for recombination 
at the floxed Oct-4 target allele since no Crc recombinase was detected in genital ridges 
from E12.5 TNAP-Cre" embryos. 
iv 
Reporter line studies showed that ZP3-Cre had the expected expression pattern. In 
mutant animals it was not possible to deduce whether the oocytes were actually 
deficient in Oct-4 protein and given the fact that all ooctytes of the correct genotype had 
undergone recombination it was also conceivable that the timing of the excision may 
have occurred too late, i.e. post the burst of Oct-4 expression as oocytes exit meiotic 
arrest, oocytes being viable due to the presence of maternal Oct-4 mRNA. The reasons 
for late excision and lack of phenotype are discussed. 
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Chapter 1 
Chapter 1: Introduction 
1.1 	Oct-4: a class V POU domain transcription factor 
Oct-4, alternatively know as Oct-3 or POU5F1, is a member of the class V POU domain 
transcriptional regulators. Oct-4 was originally identified as conferring DNA binding 
activity in extracts from embryonic stem (ES) and embryonic carcinoma (EC) cell lines 
(Lenardo et cii. 1989; Okamoto et ciL 1990). POU proteins recognise and bind a 8 
basepair (bp) recognition element, referred to as the octamer sequence, that is found in 
upstream regions of a number of genes (Ruvkun Ct cii. 1991). The Oct-4 protein is 352 
amino acids and contains a conserved POU domain of -150 amino acids, consisting of 
the POU homeodomain and POU specific domain connected by a linker region 
(Okarnoto et cii. 1990; Rosner et cii. 1990; Scholer ct cii. 1990). 	Both the POU-specific 
domain and POU homeodomain are required to achieve high-affinity site-specific DNA 
binding to the target octamer sequence ATGCAAAT (Herr et cii. 1988). The POU-
specific domain and POU homeodomain are able to bind DNA independently (Klemm 
et cii. 1996) suggesting that the linker region acts to increase the local concentration of 
DNA binding domains thus increasing the site-specific DNA binding (Ryan et cii. 1997). 
POU domain proteins have been identified from a number of species and have been 
classified into seven classes based on the POU domain sequence and the linker region 
(Ryan et cii. 1997). Studies both in vivo and in vitro have demonstrated that POU 
transcription factors regulate principle developmental processes during animal 
development (Ryan and Rosenfeld 1997. Members of class V POU domain proteins, to 
which Oct-4 belongs, are expressed during early embryonic development. 
In the mouse Oct-4 is located on chromosome 17 and maps to a position within the t 
complex that is within the major histocompatibility complex (MI-IC) (Scholer et cii. 
1 
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1990). Orthologues of Oct-4 have so far only been identified in mammals including 
human (Takeda et al. 1992), bovine (van Eijk et al. 1999) and a marsupial (Frankenberg et 
al. 2001) but none has been identified in avians such as the chicken (Soodeen-Karamath 
et al. 2001). In Xenopus, three POU proteins have been identified that have a degree of 
homology to mammalian Oct-4; XLPou-60, XLPou-25 and XLPou-91 (Hinkley et al. 
1992). These three genes exhibit a sequential pattern of expression during early 
embryogenesis and may play critical roles in the determination of cell fate and 
regulation of cell proliferation (Hinkley et al. 1992; Whitfield et al. 1995). Human and 
bovine Oct-4 genes map to a region within the MHC. They have been localised to 
human chromosome 6 (Takeda et al. 1992; Krishnan et al. 1995) and to the bovine 
chromosome 23 (van Eijk et al. 1999). The Oct-4 orthologues exhibit considerable 
similarity in sequence, genomic organisation and map position. For instance murine 
Oct-4 is highly conserved in humans (87%) and cows (87.1%) in overall protein 
sequence identity. Furthermore, comparative analysis of upstream promoter sequences 
of human, bovine and murine Oct-4 gene revealed that there were four highly 
conserved regions of homology between these species suggesting similar translational 
control mechanisms (Nordhoff et al. 2001). Interestingly the human orthologue of Oct-
4, unlike any of the other orthologues, generates two transcripts, possibly via two 
alternative splicing mechanisms or an alternative 1st  exon usage, producing two 
proteins with differing N-terminal regions (Takeda et al. 1992). The functions conferred 
by these two splice variants remains unidentified though considering each variant has 




1.2 	Expression pattern of Oct-4 during development 
Expression of Oct-4 occurs early in mouse embryogenesis in the pluripotent lineage but 
is down-regulated as embryogenesis proceeds where expression eventually becomes 
confined to cells only of the germ cell lineage. The expression pattern of Oct-4 is 
schematically illustrated in Figure 1. In unfertilised oocytes both maternal Oct-4 
mRNA and protein are present that are transported to the nucleus following 
fertilisation (Rosner et cii. 1990; Scholer et cii. 1990; Yeom et cii. 1991; Palmieri et cii. 1994). 
Significant but low levels of Oct-4 protein are detectable in 2- and 4-cell embryos 
(Palmieri et cii. 1994). Zygotic Oct-4 expression is activated prior to the 8-cell stage and 
noticeably higher levels of Oct-4 protein are detected in all nuclei throughout the 
morula stage (Yeom et cii. 1996; Palmieri et cii, 1994). Prior to blastocoel formation in the 
compacted morula a cell fate decision occurs depending on the down-regulation or 
maintenance of Oct-4 expression. This brings about the first separation of the 
extraembryonic and embryonic lineages (Okamoto et al. 1990; Rosner et cii. 1990; Scholer 
et cii. 1990). The outer cells of the morula downregulate Oct-4 expression and 
differentiate to form trophectoderm which is required for implantation and placental 
development. The inner cells of the morula maintain Oct-4 expression, they remain 
undifferentiated becoming the inner cell mass (1CM) which gives rise to the embryo 
proper plus other extraembryonic tissues. Similarly in vitro when ES, derived from the 
1CM, or EC cells derived from mouse teratocarcinomas, were induced to differentiate 
Oct-4 mRNA expression is downreguiated (Lenardo et cii. 1989; Scholer et cii. 1989). 
Both in culture and in the embryo expression of Oct-4 is associated with 
undifferentiated cell type. 
The 1CM gives rise to the epiblast (also referred to as the primitive ectoderm) and 
hypoblast (also referred to as the primitive endoderm). Oct-4 expression is only 
maintained within the epiblast (Rosner et cii. 1990; Scholer et cii. 1990; Yeom ct cii. 1990). 
3 
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The hypoblast, that surrounds the blastocoelic surface of the epiblast, is the second 
extraembryonic lineage. Just prior to implantation the hypoblast differentiates further 
into two cell lineages; the parietal and visceral endoderm. Interestingly a transient 
increase in Oct-4 expression occurs in the hypoblast before differentiation to parietal 
and visceral endoderm, neither of which expresses Oct-4 (Palmieri etal. 1994). 
During gastrulation most of the positional information concerning the body plan is laid 
down. Also at this stage in development definitive separation of gerrnline and somatic 
cell lineages occurs. Oct-4 expression, originally observed throughout the epiblast 
becomes down-regulated in an anterior to posterior direction and Oct-4 expression 
becomes restricted to the germline (Scholer et al. 1990). The epiblast is a cup-shaped 
structure, a thickening at one region of the "rim" specifies the posterior end of the 
embryo and indicates the onset of gastrulation. Epiblast cells at the anterior and lateral 
edges enter this thickening, referred to as the primitive streak, and migrate between the 
epiblast and endodermal cells giving rise to mesodermal and endodermal tissues. 
Some epiblast cells at the proximal region become segregated to the extraembryonic 
mesoderm at the embryonic/extraembryonic junction. As gastrulation continues the 
primitive streak lengthens anteriorly. Simultaneously though, the embryo is rapidly 
enlarging giving the appearance that the streak retracts posteriorly. 
On reaching day E8.5, Oct-4 expression is only observed in PGCs in the extraembryonic 
mesoderm at the base of the allantoic bud (Yeom et al. 1996). PGCs are first identifiable 
from mid-gastrulation by their strong alkaline phosphatase activity. From the allantoic 
bud the PGCs migrate to the gonadal anlagen and continue proliferating until E13.5 
when they become germ cells. This halt in proliferation is coincident with the 
beginning of sexual differentiation. Embryonic germ (EG) cells derived from the in 




Expression of Oct-4 during gametogenesis is down-regulated in a sex specific manner 
(Pesce et cii. 1998). In male embryos, Oct-4 expression is maintained in postproliferative 
prospermatogonia. After birth Oct-4 expression continues in undifferentiated A 
spermatogonia, however on 	reaching spermatogenic maturation expression 	is 
downregulated completely. In female embryos, Oct-4 is expressed until E15.5 in 
oocytes until the zygotene/pachytene stage of meiotic prophase I is reached. 1-3 days 
after birth, Oct-4 is re-expressed in meiotically arrested developing oocytes at low levels 
(Pesce et cii. 1998). In full grown oocytes, that are stimulated to complete meiosis there 
is a dramatic burst of Oct-4 expression (Pesce et cii. 1998). This first occurs in oocytes at 
12 - 14 dpp and thereafter in full grown oocytes selected to complete meiosis in the 
adult female (Pesce et cii. 1998). The expression pattern of Oct-4 during oogenesis is 
depicted schematically in Figure 1.2. 
A more detailed discussion of the specification and development of germ cells and 
oogenesis are found in sections 1.6 and 1.7. 
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Figure 1.1 Expression of Oct-4 in the mouse embryo during embryogenesis. Light blue indicates 
the presence of maternal Oct-4 mRNA, dark blue indicates the presence of Oct-4 protein: 











Preimplantobon embryo (E6.5) 
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oocyte i division (2N) division occurs 
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I I 
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Coincident with late prophase I 
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+ ++ 
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At 12-14 dpp first dramatic up-regulation in first 
cohort of developing oocytes stimulated to complete 
Coincident with mid prophase I (zygotene/pachytene) 
meiosis. 	This up-regulation is coincident with 
completion of prophase I and marks exit of growth 
arrest. 
After this point those oocytes stimulated to exit 
growth arrest exhibit a dramatic up-regulation in Oct- 
4 expression. This occurs at different times for 
different oocytes subject to when a particular oocyte 
is selected to exit growth arrest and continues 
throughout the reproductive life of the mouse 
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1.3 	Regulation of Oct-4 expression 
1.3.1 Regulatory features of the Oct-4 5'UTR 
Distal 	 Proximal 	Proximal 
enhancer (DE) 	enhancer (PE) 	promoter 	Oct-4 
—2-3 	 4— 5 - 
site 2A 	Site LA lB 	GC box lIRE 
Distal enhancer: oocyte through to morula stage, 1CM, PGCs, [Sand EG cells 
Proximal enhancer. epiblast, [C cells 
Figure 1.3 Genomic structure of the Oct-4 gene. Oct-4 consists of five exons, depicted as blue 
boxes. The upstream regulatory regions depicted include the promoter, proximal enhancer and 
distal enhancer. Within these regulatory regions grey boxes represent factor binding sites. The 
activity of each of the enhancer elements in different cell types is indicated. HRE = hormone 
responsive element. 
Transgenic analysis of Oct-4 expression in the developing mouse embryo using a LacZ 
reporter construct identified an 18kb region upstream of the Oct-4 open reading frame 
(ORF) sufficient to reproduce endogenous gene expression (Yeom et al. 1996). Further 
analysis of this region by deletion analysis identified three cis-regulatory regions 
necessary for endogenous gene expression. Located 5', in close proximity to the Oct-4 
transcription initiation site is the proximal promoter, upstream of which are located 
two enhancer elements; the proximal (PE) and distal enhancers (DE). The Oct-4 gene 
consists of five exons that encode a -1.5kb mRNA transcript and the genomic structure 




Within the Oct-4 proximal promoter are a series of overlapping DNA binding sites that 
are recognised by specific DNA binding proteins (Ovitt et cii. 1998). These include a GC 
box, three repeated half sites of the consensus hormone response element (HRE) and a 
putative binding site for a nuclear orphan receptor (ELF) is present (Schoorlemmer et cii. 
1994; Sylvester et cii. 1994). Oct-4 lacks a TATA box and Spi transcription factors are 
believed to play a role in initiating transcription from promoters lacking a TATA box. 
The lack of TATA box may be an important mechanism by which gene expression can 
be restricted in undifferentiated cells. In preimplantation embryos, ES and EC cells 
transcription of Oct-4 would depend on Spi binding, while the absence of the TATA 
box in differentiating cells would facilitate its down-regulation. In vitro, mutations in 
the GC box in ES and EC cells prevent Oct-4 expression, however in vivo expression of 
Oct-4 is unaffected possibly suggesting a degree of genetic redundancy within the Spi 
family members (Minucci et cii. 1996). In another study, analysis of the activity of Oct-4 
promoter CC box in Spi deficient ES cells showed that Oct-4 mRNA and protein levels 
were comparable to wildtype ES cells (Pesce et cii. 1999). On further analysis of CC-box 
binding proteins in extracts from the Spl  ES cells Sp3, another member of the Spi 
transcription factor family was identified and found to efficiently bind to the Spi site. 
These results may indicate that Sp3 may complement Spi function in ES cells and 
potentially other CC-box binding proteins may be involved (Pesce et cii. 1999). Also 
present are three repeated half-sites of the consensus hormone response element (HRE) 
which resemble a retinoic acid response element (RARE) (Schoorlemmer et cii. 1995). 
This site is recognised by several receptors including retinoic acid (RA) and retinoid X 
receptors (RXR) which belong to the steroid thyroid hormone receptor family. 
The activity of the two enhancers is temporally regulated such that the DE drives 
expression in the morula, 1CM and PCCs whilst the PE is active in the epiblast (Yeom Ct 
cii. 1996) ES and EC cell lines derived from specific embryonic developmental stages 
also reflect this enhancer usage. In ES cells isolated from the 1CM Oct-4 expression is 
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driven by the DR In EC cells Oct-4 expression is driven by the FE. In viva the exact 
timing of the switch in promoter usage is unknown, however it would appear that 
control of Oct-4 gene expression switches from the PE to the DE as FGCs are allocated 
to the extraembryonic mesoderm during gastrulation (Yeom et at. 1996). 
Within the FE a cis-acting element that responds to RA repression is present, though it 
does not contain a recognisable RA receptor binding site (Okazawa et at. 1991). This 
element can be divided into two regions, IA and IB, only 1A remains occupied in vitro 
in undifferentiated ES and EC cells (Minucci et al. 1996). This site is also CC rich and 
related to the Spi binding sequence found in the promoter. The DE element contains a 
site called 2A that is an inverted version of site 1A in the FE. In vivo genornic 
footprinting analysis demonstrated that this site is also occupied in undifferentiated ES 
and EC cells (Minucci et at. 1996). 
1.3.2 Retinoic acid (RA) and downregulation of Oct-4 expression 
Considerable research has been carried out to investigate Oct-4 downregulation and 
cell differentiation using the ES and EC model systems. Treatment of ES or EC cells 
with RA induces differentiation and represses Oct-4 mRNA and protein expression 
(Lenardo et al. 1989; Scholer et at. 1989; Okamoto et al. 1990). Within the Oct-4 
promoter-enhancer region are several RA-response elements (RAREs). Expression of 
Oct-4 is controlled by a cell specific enhancer, RARE1, located 1.2kb upstream of the 
initiation site this contributes to RA-mediated repression (Okazawa et al. 1991). RARE1 
does not contain a typical recognition for RA receptors (RAR), however a RARE is also 
present in the Oct-4 promoter (RARE0ct) and it would appear to be this site that 
mediates RA induced repression in RA differentiated EC cells (Pikarsky et at. 1994; 
Schoorlemmer et al. 1994). Within the Oct-4 upstream region are several target 
sequences for RA-mediated repression including the FIRE which can bind members of 
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the nuclear hormone receptor subfamily (Ruvkun et at. 1991; Schoorlemmer et cii. 1994; 
Sylvester et at. 1994). The orphan receptors ARP-l/COUPTFII and EAR-3/COUP-TF1 
are induced by RA treatment of EC cells and act as negative regulators at the Oct-4 
locus (Ben-Shushan et al. 1995). 
RA appears to cause loss of factor binding from the enhancer/promoter regions at the 
Oct-4 locus. For instance in RA treated ES and P19 EC cells factors are displaced from 
the proximal enhancer as shown by genomic footprinting (Minucci et cii. 1996). Also, 
although there appears to be no RARE in the distal enhancer, factors binding to site 2A 
in the distal enhancer are also lost (Minucci et al. 1996). This may indicate that Oct-4 
repression brought about by RA treatment in vitro occurs as a result of simultaneous 
coordinated loss of activating factors from the proximal and distal enhances. However, 
similar experiments performed on F9 EC cells did not give the same results; factor(s) 
were only lost from the proximal enhancer and not from the promoter or distal 
enhancer. This may reflect intrinsic differences between the two cell lines. F9 cells are 
though to represent a model system for differentiation of parietal and visceral 
endodermHogari et at. 1981). Since Oct-4 expression decreases slowly even after 6 days 
of RA treatment this may reflect the in vitro situation where prolonged expression is 
associated with the differentiation of the parietal endoderm (Palmieri ct cii. 1994). 
1.3.3 Methylation and downregu/at/on of Oct-4 expression 
Methylation is one is the molecular mechanisms that control gene expression (Bird 
2002). During embryogenesis DNA methylation patterns undergo dramatic changes 
such that a global loss of methylation occurs in the mammalian preimplantation 
embryo prior to 16 cell stage. The DNA remains unmethylated until implantation, at 
which point an extensive wave of de novo methylation occurs and only those genes 
containing CpG islands escape, such as housekeeping genes (Bird 2002). Tissue 
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specific genes are subject to selective demethylation later during development (Bird 
2002). 
During mouse embryogenesis a specific restriction of Oct-4 expression occurs such that 
Oct-4 becomes confined to the pluripotent lineage; the germ cells. This is also reflected 
in vitro where Oct-4 is down-regulated in differentiating cells and maintained in 
undifferentiated ES cells. Differentiation of ES or EC cells with retinoic acid results in a 
dramatic reduction in Oct-4 expression and this is associated with loss of occupancy of 
transcription factors from the Oct-4 promoter and enhancer regions (Minucci Ct at. 
1996). Furthermore, this is also associated with increased methylation and changes in 
chromatin structure in the upstream regulatory regions that include the promoter and 
proximal enhancer elements (Ben-Shushan et at. 1993). Recent work by Gidekel and 
colleagues has shown that in vivo the Oct-4 gene is unmethylated from the blastocyst 
stage and starts to undergo de novo methylation at E6.5 (Gidekel et al. 2002). This is of 
interest since Oct-4 gene remains unmethylated whilst the rest of the genome is 
undergoing de novo methylation and would indicate that there is a protection 
mechanism. Using a series of stable transfection assays in EC cells it was possible to 
identify a cis-specific demodification element within the Oct-4 proximal enhancer 
sequence. Mutations within this site resulted in methylation, thereby preventing 
transcription, and in vivo indicate that the proximal enhancer protects the DNA from de 
novo methylation in E6.25 epiblast cells. Both in vitro and in vivo it would appear that 
DNA methylation is sufficient to inhibit Oct-4 expression (Gidekel et at. 2002). 
1.4 	Role of Oct-4: target genes and functional partners 
An insight into the biological roles of Oct-4 has been achieved both by targeted 
inactivation at the Oct-4 locus, analysing interactions with other regulatory proteins 
and identification of downstream target genes. Generation of a targeted null mutation 
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at the Oct-4 locus has demonstrated that Oct-4 expression is absolutely required for the 
identity of the pluripotent founder cell population in the mammalian embryo (Nichols 
et at. 1998). Embryos deficient in Oct-4 develop to form blastocysts, but cells allocated 
to the presumptive inner cell mass (1CM) region are not pluripotent and instead 
differentiate along the extraembryonic trophoblast lineage (i.e. differentiation along a 
somatic lineage). 
Oct-4 can act both as a transcriptional activator or repressor either independently or 
synergistically with other factors (Pesce etal. 2001). 
1.4.1 Oct-4 and functional partners 
Oct-4 is able to activate target gene expression by interaction with co-activators or 
synergistic action with other factors. The adenoviral protein EIA was the first protein 
found to functionally interact with Oct-4 (Scholer et at. 1991). EIA and also other E1A-
like proteins in stem cells enable distant dependent transactivation by bridging Oct-4 
molecules to the basal transcription machinery. The EIA-Oct-4 interaction does not 
appear to require DNA binding on the part of EIA (Scholer etal. 1991). 
Other Oct-4 target genes require the synergistic action of factors where both Oct-4 and 
the factor bind to each other and their target recognition sequences. For instance, an 
enhancer element (Curatola et at. 1990) located within the 5' UTR of the fibroblast 
growth factor 4 (FGF-4) gene contains an octamer motif and an adjacent binding site to 
which the high motility group (HMG) transcription factor Sox-2 can bind. Oct-4 and 
Sox-2 bind cooperatively and activate transcription synergistically (Yuan et al. 1995). 
Both factors are absolutely required for enhancer activity since they appear to impart an 
allosteric change in each protein that is required for transcriptional activation of FGF-4 
(Ambrosetti et al. 2000). interestingly Sox-2 itself appears to be under the control of the 
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Oct-4/Sox-2 complex in ES cells (Tomioka et al. 2002). The Oct-4/Sox-2 complex also 
positively regulates Utf 1, a transcription factor expressed in the 1CM, by binding to an 
enhancer element in the 3' UTR (Okuda et al. 1998; Nishimoto et al. 1999). Overall this 
indicates that Oct-4/Sox-2 transcriptional activation depends on reciprocal modelling of 
both proteins directed in a binding site specific manner. Another regulatory factor that 
binds to Oct-4 has been identified; Rox-1 (Ben-Shushan et al. 1998). Rox-1 in 
combination with Oct-4 or Oct-6 binds DNA recognition elements in the Rex-1 
promoter to regulate transcription. 
1.42 Oct-4 target genes 
Oct-4 has been reported to bind to the regulatory regions of Rex-1 (Rosfjord et al. 1994; 
Ben-Shushan et al. 1998), FGF-4 (Schoorlemmer et al. 1991), the genes encoding human 
platelet-derived growth factor (PDGF) cc receptor (Kraft et al. 1996), the cc and 
subunits of the human chorionic gonadotrophin (HGC) (Liu et al. 1997), a murine 
glucose transporter (Saijoh et al. 1996) and osteopontiri (opn) (Botquin et al. 1998). 
Rex-1 and FGF-4 are expressed in ES and EC cells and expression of each is down-
regulated on differentiation (Hosler et al. 1989; Schoorlemmer et al. 1991; Rosfjord et al. 
1994). In vivo Rex-1 and FGF-4 are co-expressed with Oct-4 in the 1CM (Rogers et al. 
1991; Scherer et al. 1996). in Oct-4 homozygous null embryos which lack true 1CM, 
trophoblast proliferation was not maintained and could only be restored by addition of 
FGF-4 (Nichols et al. 1998). Oct-4 directed gene expression of FGF-4 would appear to 
result in paracrine growth factor signalling from the pluripotent cell population to the 
trophectoderm (Nichols et al. 1998). Targeting inactivation at the Rex-i locus to 
generated homozygous null ES cells resulted in ES cells that were unable to 
successfully differentiate into visceral endoderrn on retinoic acid treatment alone 
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suggesting that Rex-1 plays a role in differentiation of this tissues type (Thompson et cii. 
2002). 
Oct-4 has been shown to repress several target genes. Binding of the Oct-4 protein to 
the immunoglobin heavy chain enhancer in F9 EC cells resulted in repression of 
expression (Lenardo et cii. 1989). Octamer motifs are found in the proximal promoters 
of the x and f3 subunits of the HGC genes that are required for implantation and 
maintenance of pregnancy (Liu Ct al. 1997). Each of the subunits were expressed as the 
trophectoderm began to differentiate, a time at which Oct-4 expression is down-
regulated in the peripheral cells in the morulae. This indicated that HGC expression is 
repressed by Oct-4, and activated in its absence, its activation correlating to a time at 
which the embryo would require to implant and develop further. Oct-4 can act as a 
corepressor of FoxD3 and prevent activation of the promoters of the early endodermal 
transcription factors FoxAi (previously HNF-3a) and FoxA2 (previously l-INF-3p)(Guo 
et al. 2002). FoxAi, FoxA2 and FoxD3 belong to the Forkhead Box (Fox) family of 
transcriptional regulators. This family is strongly implicated in early embryonic 
lineage decisions, particularly the development of the endoderm and subsequent 
endodermal organogenesis. FoxD3 can activate the FoxAi and FoxA2 promoters, 
however in the presence of Oct-4 activation is prevented due to Oct-4 physically 
interacting with FoxD3. Oct-4 alone cannot bind or activate the FoxAl or FoxA2 
promoters alone. Overall this data showed that Oct-4 can prevent ES cell lineage 
differentiation gene cascades by functioning as a corepressor of a lineage-specific 
transcription factor (Guo et al. 2002). 
The majority of Oct-4 gene targets appear to have some direct role in differentiation but 
there are some exceptions. For instance, OPN protein is secreted by cells of the 
preimplantation embryo and binds to specific integrin subtypes and can modulate cell 
adhesion/migration Oct-4 and OPN are coexpressed in the preimplantation mouse 
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embryo and repressed during differentiation of ES and EC lines. An Oct-4 binding site 
has been identified in the OPN gene (Botquin et al. 1998). In the embryo OPN niRNA is 
found from in the epiblast and hypoblast. Oct-4, though it becomes restricted to only 
the epiblast there is a transient increase in the hypoblast as it begins to differentiate and 
migrate along the surface of trophectoderm. This overlapping expression in the 
premigratory endodermal cells suggested that Oct-4 is involved in the regulation of 
OPN expression and that OPN is involved in cell migration. Interestingly there is a Sox 
recognition sequence within the OPN promoter, but binding of Sox-2 appears to repress 
Oct-4 mediated activation at the OPN locus (Botquin et al. 1998). The reasons for these 
opposing actions remain unclear and require further characterisation (Ovitt etal. 1998). 
1.5 	Role of Oct-4 and cell potency 
Oct-4 would appear to play an essential role in maintaining the pluripotent state of a 
cell, and potentially in the specification of the germ cell lineage. Expression of Oct-4 
occurs during early mouse embryogenesis and Oct-4 expression is confined to 
undifferentiated or differentiating cells of the embryo. Targeted inactivation at the Oct-
4 locus demonstrated that Oct-4 is absolutely required for the identity of the pluripotent 
founder cell population (Nichols ct al. 1998). This and other studies suggest that the 
"decision" leading to Oct-4 expression or repression in a totipotent cell is one of the first 
events deciding whether a cell remains pluripotent or enters a somatic differential 
pathway (Nichols et al. 1998). Furthermore, it has been demonstrated that the precise 
level of Oct-4 governs three distinct cell fates (Niwa et al. 2000). In ES cells a critical 
level of Oct-4 expression is required to maintain a self-renewal capacity. Repression of 
Oct-4 expression directs dedifferentiation to trophectoderm, and elevation of 
expression directs differentiation along a primitive endoderm and mesoderm fate 
(determined by the presence of diagnostic markers for endoderm and mesoderm). 
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During gastrulation Oct-4 expression is progressively down regulated in an anterior to 
posterior manner and expression becomes confined to the germ cells of the embryo 
(Rosner et at. 1990). The role of Oct-4 in primordial and maturing germ cells has not 
been elucidated thought it has been speculated that Oct-4 is required for maintaining 
totipotency (Pesce et at. 2000). Prior to gastrulation, primordial germ cell (PGC) 
precursors are found within the proximal region of the epiblast. On formation of the 
primitive streak pluripotent cells within the epiblast region migrate to the 
extraembryonic mesoderm, some of which acquire a PGC fate. One hypothesis 
suggested for the allocation of germ cells in this manner is that this migratory 
mechanism may reflect the requirement for germline competent cells to avoid signals 
that drive somatic differentiation; instead maintaining a totipotent phenotype (i.e. 
maintaining Oct-4 expression) (Pesce et at. 1999). Furthermore expression of Oct-4 in 
the epiblast relies on the activity of the proximal enhancer, whilst expression in germ 
cells relies on the distal enhancer (Yeom et at. 1996). This enhancer switch could ensure 
that Oct-4 expression is maintained throughout the epiblast until specification of the 
germ cells. At this point the proximal enhancer is then switched off, whilst Oct-4 
expression is maintained by the distal enhancer in germ cell precursors that must 
remain totipotent. 
Expression of Oct-4 in PGCs persists until the onset of maturation in oogenesis and 
spermatogenesis; a stage coincident with entry to the meiotic cycle and coincident with 
meiotic arrest (Pesce et at. 1998). This may indicate that Oct-4 downregulalion at this 
point may be one of the factors involved in determining commitment to meiosis. 
Further analysis of the maturation stages of oocytes has revealed that Oct-4 is 
upregulated dramatically in oocytes as they exit meiotic arrest and complete meiotic 
prophase I possibly suggesting subsequent roles of Oct-4 in oocyte growth and/or the 
acquisition of meiotic competence. 
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1.6 	Specification and development of the germ cell lineage in the mouse 
1.6.1 Specification of the germ ce/I fin eage 
In the mouse, unlike Drosophila rncianogastcr and Ccienorhabditis elegans, development of 
the germ cell lineage is not a result of localisation of maternal components in the early 
embryo (Wylie 1999). Instead, beginning at approximately E6, cells derived from the 
proximal epiblast migrate into the extraembryonic mesoderm, a subset of which 
differentiate to form a precursor pool of approximately 50 primordial germ cells (PGCs) 
(Lawson 1994; Tam et al. 1996). PGCs are first detected at E7 - 7.25 as a population of 
alkaline phosphatase positive cells at the base of the allantois (Ginsburg et al. 1990) and 
have been observed in vivo using GFP under the control of the Oct-4 promoter (Yeom et 
al. 1996; Anderson et al. 2000). In the mouse, unlike in other organisms there is no 
evidence of maternally deposited germ plasm inherited by the germ cells (Zemicka-
Goetz 1998; Ciemerych et al. 2000). In Drosophila, zebrafish and Xenopus, vasa and 
nanos are expressed in the early germ cells, but in the mouse these markers are not 
expressed until much later when the germs cells have completed their migration 
(Tanaka et al. 2000; Toyooka et al. 2000). 
Fate determination in the epiblast is dependent on cell position suggesting the influence 
of local signaling factors. In the case of germ cells, heterotopic transplantation 
experiments in a E6.5 mouse embryo showed that distal epiblast cells when 
transplanted to the proximal region had a germ cell fate (Tam et cii. 1996). Likewise 
when proximal epiblast cells were transplanted to the distal region they gave rise to 
distal cell fates. This would suggest that at E6.5 the tissues surrounding the proximal 
epiblast mediate a signal that induced germ cell fate. 
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Bone morphogenic proteins (BMPs) have been shown to be required for 
extraembryonic ectoderm to regulate the formation of the germs cells and related 
lineages. BMP4 and BMP8b, members of the transforming growth factor type 1 
superfamily (TGFI3) of growth factors, have overlapping expression patterns in the 
extraembryonic ectoderm. Brnp4 homozygous null mutants completely lack PCCs and 
an allantois (Lawson et al. 1999), whereas Bmp8b homozygous mutants exhibited a 
severe defect in germ cell numbers, or none at all and poor development of the allantois 
(Ying et al. 2000). Similar phenotypes were also observed in SMADI and SMAD5 
homozygous mutant embryos. This is perhaps not surprising since SMADs have been 
demonstrated to be the downstream signaling mediators for BMPs (reviewed in von 
Bubnoff et al. 2001). SMAD5 signaling appears to play a more general role in PGC 
generation and localisation whereas SMADI signaling is absolutely essential for the 
initial commitment of cells to the germ cell lineage (Chang et al. 2001; Hayashi et at. 
2002). 
Recent work has further investigated the related roles of BMP4 and BMP8b in FCC 
specification. Both BMP4 and BMP8b mutant animals exhibit a dose dependent 
reduction in germ cell number depending whether the animal is heterozygous or 
homozygous for the mutation. To elucidate whether BMP4 and BMP8b functioned as 
homodimers or heterodimners epiblasts of E6.0-6.25 embryos were co-cultured with 
BMP4 and BMP8b proteins expressed by COS cells allowing investigation into their 
effect on FCC induction. The results showed that BMP4 and BMP8b homodimers alone 
were unable to induce FGCs whereas they could in combination, suggesting that 
signaling via two BMP pathways are simultaneously required for PGC specification 
(Ying et al. 2001). Furthermore, the FGCs defects in the BMP4 homozygous mutant 
could not be rescued by BMP4 homodimers but the defect in the BMP8b mutant could 
be rescued by the presence of BMP8b homodimers indicating that BMP4 proteins are 
required for epiblast cells to gain germ-line competency prior to the synergistic action 
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of BMP4 and BMP8 (Ying ct at. 2001). BMP4 is also expressed in the extraembryonic 
mesodenn and is also required for allantois development and the location and survival 
of PGCs (Fujiwara et at. 2001). Taken together, these results appear to suggest that 
BMP4 has two roles; it is firstly involved in the establishment of precursors from the 
epiblasts and the allocation of these precursors to the PGC or allantois lineages and 
secondly in the differentiation and survival of these cell types once they have been 
specified. Furthermore in vitro, treatment of epiblast cells from E5.5 - E6.0 embryos 
with BMP4 was sufficient to induce a PGC phenotype (Pesce et al. 2002). 
1. 6.2 Germ cell migration in the mouse 
Germ cells in the mouse are specified in the posterior rim of the epiblast by local 
signaling and from here they migrate to an extraembryonic structure, the allantois, at 
E7.5. From the allantois, the germ cells migrate to the genital ridges via the hindgut 
(reviewed in Wylie 1999). Using a transgenic mouse line expressing GFP under a 
truncated Oct-4 promoter permits visualization of living germ cells in viva and has 
begun to address the behavior of germ cells during the migratory process. Time lapse 
analysis showed that PGCs actively migrate from the time they exit the posterior 
primitive streak and enter the allantois (Anderson et at. 2000). Confocal microscopy in 
conjunction with time lapse imaging showed that at E9.0 the germ cells moved rapidly 
but are confined to the hind-gut (Molyneaux et al. 2001). Subsequently, at E9.5, the 
germ cells exited the hindgut and invaded the body wall prior to the mesentery 
forming; however, this movement does not appear to be directed towards the sites of 
the prospective genital ridges. Germ cells only begin to show directional movement 
towards the genital ridges at E10.5 and by E11.5 the majority of germ cells have 
colonised the genital ridges (Molyneaux et al. 2001). Experiments in culture have shown 
that germ cells move preferentially towards the genital ridges suggesting that this 
tissue sends out an attractive signal (Godin et at. 1990). In vivo it appears that any germ 
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cells that remains behind in the hind-gut mesentery do not migrate directionally any 
further and are lost, possibly by apoptosis (Molyneaux et cii. 2001). 
Germ cells take from E7.5 and E10.5 embryos have distinct migratory morphologies. 
They often have a tear drop shaped appearance and/or have pseudopodia extending 
from one germ cell to the next. During the migratory process, the germ cells do not 
migrate independently and instead associate with one another via cytoplasmic 
processes that form an extensive interlinking network (Gomperts et cii. 1994). Post-
migratory germ cells in the genital ridges are found in tight clusters without any 
pseudopodia. Both of these processes are also observed in vitro; on disaggregating and 
culturing germ cells from embryonic tissues on mouse embryonic fibroblasts, the germ 
cells first extend processes that contact other germ cells then segregate themselves from 
other cell types by forming tight non-motive invasive clusters of PGCs (Gompert et al. 
1994) 
Several genes are known to be required for germ cell migration/survival. Recently the 
mouse germ cell deficient (gcd) mutation (Pellas et al. 1991; Duncan et cii. 1995), 
characterised by reduced numbers of PGCs and adult sterility was found to be 
attributed to partial deletion of the proliferation of germ cells (pog) gene and results in 
reduced PGC proliferation (Agoulnik et al. 2002). Mice lacking an RNA recognition 
motif/ribonucleoprotein-type RNA binding protein, TIAR, that is highly expressed in 
germ cells fail to develop spermatogonia or oogonia (Beck et cii. 1998). This is due to a 
severely reduced survival rate of migrating PGCs and in mutant animals none are 
present in the genital ridges at E13.5. The exact role of TIAR in promoting PGCs 
survival in the genital ridge is unclear, however it has been hypothesised that TIAR 
may play a role in signaling or to play a role in RNA stability of growth factors 
involved in promoting the survival and proliferation of PGCs (Beck et cii. 1998). These 
include steel factor, LIF, basic fibroblast growth factor and their respective receptors. 
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Two of the most well studied and characterised genes know to affect germ cells are 
dominant white spotted (W) and steel (Si) (Godin et al. 1991; Buehr et al. 1993). 
Mutations in either of these genes have severe consequences since PGC are unable to 
populate the genital ridges. This is due to the cells being unable to proliferate and their 
migration is also affected. W and 51 encode the c-kit tyrosine receptor, expressed by 
germ cells, and the c-kit ligand stem cell factor (SCF), expressed in the mesentery, 
during germ cell migration. Migrating germ cells that stray from the Si expression 
migratory pathway die, possibly due to apoptosis (Keshet et al. 1991; Motro etal. 1991). 
In vitro studies have confirmed the role of W and SL in culture but also suggest addition 
factors are likely to be involved. Germ cell isolated from genital ridges and cultured on 
a mouse embryonic fibroblast (STO) cell line require the presence of SCF for their 
survival in this in vitro system (Dolci et al. 1991; Godin et al. 1991). The rate of 
proliferation can also be increased by the addition of LIF (Matsui et al. 1991). The 
simultaneous addition of these factors appear to suppress apoptosis in vitro (Pesce ef al. 
1993). 
Adhesion molecules are thought to play an essential role during germ cell migration 
and development. Cadherins have been proposed as the main candidate molecules that 
govern the germ cell interactions due to the fact that in both male and female mice 
PGCs express F- and E- cadherins during and after migration, and N-cadherin in post 
migratory PGCs (Wu et al. 1993; Lin et at. 1996; Packer et al. 1997). Blocking E-caclherin 
interactions using an anti-E-cadherin blocking antibody on E10.5 slice cultures caused 
defects in germ cell migration in the explants (Bendel-Stenzel et al. 2000; Dc Feici 2000.-
Di 
;
Carlo et al. 2000). P-cadherin targeted knockout mice are fertile and there was no 
apparent germ cell migratory phenotype (Radice et al. 1997). Targeted mutations of N-
and E-cadherin genes resulted in early embryonic lethality and as a consequence their 
role in germ cell migration cannot be analysed by this approach (Radice et al. 1997). A 
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second potential candidate for germ cell adhesion is integriri. The 131 subunit of 
intergrin appears to be required by germ cells during colonisation of the genital ridges. 
However, a number of other integrin subunits are expressed in germ cells including 0, 
c6, and V and targeted deletion of these genes did not result in any apparent germ 
cell phenotype (Anderson et al. 1999). 
.1.6.3 Germs ce//s in the genital ridge 
GCs in the mouse first enter the genital ridges between ElO - Ell as the actual ridges 
are developing. By E11.5 a distinct boundary is apparent between the genital ridge and 
the mesonephros making the entry of further germ cells unlikely. From the original 
pool of approximately 50 PGCs, there are some 12 successive doublings resulting in 
approximately 25 000 germ cells in each genital ridge by E13.5 (Tam et cii. 1981). 
On entering the genital ridge the germ cells continue proliferating but they undergo a 
marked change in phenotype. The germ cells remain positive for alkaline phosphatase 
activity but become more rounded in shape and are less motile on explantation 
(Donovan et al. 1986). A number of other germ cells markers also begin to be 
expressed. Stage-specific-antigen-1 is first evident in genn cells at E9.5 and expressed 
until E12.5 (Marani et cii. 1986). Germ cell nuclear antigen is first detected at E11.5 in 
germ cells within the genital ridge and is expressed in both male and female germ cell 
lineages until they reach the diplotene/dictyate stage of the first meiotic division 
(Enders et cii. 1994). The mouse homologue of Drosophila vasa (Mvh) is expressed in 
germ cells within the genital ridge, and in spermatocytes and round spermatids 
(Fujiwara et al. 1994). 
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1.7 	Oogenesis and foil iculogenesis in the mouse 
Close coordination between the developing germ and somatic cells in the mammalian 
ovary is required for the generation of viable eggs. During the reproductive life of the 
female, cohorts of primordial follicles are recruited periodically into a growth phase 
that results in meiotic maturation and ovulation of mature eggs into the oviduct in 
preparation for fertilisation. 
1.7.1 Fo///cu/ogenesis and opgenesis are coup/ed processes 
During folliculogenesis, the oocyte grows as the surrounding granulosa cells proliferate 
and differentiate. Completion of maturation and the first meiotic division occurs as the 
oocyte is ovulated into the oviduct in preparation for fertilisation. This process begins 
in the late stages of embryonic development when the primodial germ cells entered 
meiosis and arrest at the end of prophase I (dictyate in mice). These dictyate oocytes in 
the neonatal ovary subsequently become surrounded by a layer of flattened pre-
granulosa cells, which in turn, are surrounded by a basal lamina to form primordial 
follicles where the oocyte itself has a diameter of approximately 12 - 15.tm (Hirshfield 
1991). This pool of primordial follicles represents the entire component of germ cells 
available for reproduction after birth. 
After birth cohorts of primordial follicles are periodically recruited to enter a three 
week growth phase. This is an ongoing cyclic process and continues throughout the 
reproductive life of the mouse. During this time the maturing oocytes grow in 
diameter from 12-15 to 75-85 Vtm. Concomitant with the growth of the oocyte, the 
surrounding granulosa cells become cuboidal in shape forming primary follicles. The 
granulosa cells continue to proliferate further, forming a pre-antral follicle that consists 
of multiple layers of granulosa cells surrounding the oocyte within the follicular 
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basement membrane. The transition from pre-antral to an antral follicle is brought 
about by a surge of gonadotrophins, follicle-stimulating-hormone (FSH), that occurs 
after puberty (Kumar et cii. 1997). Oocytes within large antral follicles remain arrested 
due to a continued interaction with the surrounding granulosa cells (Bornslaeger et cii. 
1986). Large antral follicles are approximately 600pm in diameter and the oocyte 
within has a diameter of 75 —85 im. 
Ovulation occurs in response to a surge of luteinising hormone (LH) and this marks the 
end of folliculogenesis (Lee et cii. 1996). At ovulation full grown oocytes complete their 
first meiotic division, extrude the first polar body and become arrested at metaphase II 
(Richards et cii. 2002). Noticeably, there is a considerable reduction in the number of 
follicles that ovulate compared to the number of primordial follicles originally recruited 
for growth. This is due to follicles undergoing atresia (Richards 1980; Hirshfield 1989). 
Atresia tends to occur at pre-antral and antral stages but can occur earlier in follicle 
development and appears to be intrinsic to the oocyte or occur as a consequence of 
granulosa cell death. The reasons for this remain unclear. 
Folliculogenesis and oogenesis are tightly coupled processes that are coordinated via 
gap junction communication. Signals from granulosa cells regulate meiotic arrests, 
promote oocyte growth and assist resumption of meiosis and maturation (Epifano et cii. 
2002). Likewise, the oocyte secretes signals that induce follicle formation, promote 
granulosa cell architecture, regulate steriodogensis and maintain the structure of the 
developing follicle (Eppig 2001). 
1.72 Qocyte -specific factors affecting folilcu/ogenesis 
Elucidating the critical events in ovarian development has been assisted by the 
identification of a number of genes that are exclusively expressed in the oocyte. The 
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gene identified so far appear to function as multipurpose factors throughout 
folliculogensis and/or early development. 
Coordination of the expression of the three zona pellucida genes (Zpl, Zp2, Zp3) has 
been attribute to Factor In the Germline (FIGcx), a germ cell specific basic helix-loop-
helix (bHLH) transcription factor (Liang Ct cii. 1997). Female mice that are null for FlGcx 
are infertile (Soyal et cii. 2000). In these animals, primordial follicles were not formed 
despite null oocytes becoming meiotically arrested at prophase I during embryonic 
oogenesis. The ovaries become devoid of oocytes within a week after birth and prior to 
this no ZPI, ZP2 or ZP3 transcripts are detected. This suggested that FlGa plays a 
regulatory role in the expression of two oocyte specific gene pathways; those that 
initiate oogenesis and regulate the three genes encoding the zona pellucida. 
Furthermore, the persistence of FIGa in the adult females suggested that this gene may 
regulate other additional pathways that are required for normal ovarian development. 
On entering the growth phase of follicle development, oocytes secrete the Growth and 
Differentiation Factor 9 (GDF9) and Bone Morphogenic Protein 15 (BMP15). GDF9 
belongs to the TGFJ3 family, and during folliculogenesis it is involved in the promotion 
of early granulosa proliferation and induction of differentiation of cumulus cells in the 
antral follicle (Elvin et al. 1999). Follicles in female mice deficient in GDF9 failed to 
grow beyond the primordial due to a block in follicle growth (Dong et cii. 1996). Oocyte 
growth and zona pellucida formation occur normally, but other aspects of oocyte 
differentiation are abnormal. This data suggested that GDF-9, an oocyte-derived 
growth factor, was required for the development of the follicle itself (Dong et cii. 1996) 
BmplS, also know as Gdf9b, has a high degree of homology (52%) with GDF9 and is 
also involved in the stimulation of granulosa cell proliferation (Carabatsos et cii. 1998; 
Dube et cii. 1998; Otsuka et cii. 2001) and appears to play a role in the regulation of FSH 
receptor transcripts (Otsuka et cii. 2001). Female mice deficient for BMIPI5 are sub-fertile 
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with reduced litter sizes due to ovulatory defects (Yan et at. 2001). Furthermore, 
analysis of Bmp15-7  I Gdf9 and BMP15-/-  I Gdf9 double mutants showed that BMPI5 
and GDF9 appear to act synergistically in ovarian function (Yan et at. 2001). 
1.7.3 Oocyte maturation 
Melotic maturation 
Acquisition of meiotic maturation competence by the oocyte occurs at two stages 
during growth. Firstly the germ cell gains the ability to undergo germinal vesicle 
breakdown (GVBD) progressing to metaphase I (Canipari et al. 1984; Chesnel et at. 
1995), and then secondly progresses to metaphase II (Sorensen et at. 1976; 
Wickramasinghe et at. 1991). The resumption and completion of meiosis in the oocyte 
involves three factors; Maturation Promoting Factor (MPF), a proto-oncogene MOS and 
Mitogen Activated Protein Kinase (MAPK). 
MFP activity appears to be a universal regulator of mitotic and meiotic cell cycles. MPF 
is a protein-serine/threonine kinase that consists of a catalytic subunit, p34cdc2,  and a 
regulatory subunit, cyclin B (O'Keefe et al. 1991). MPF activity rapidly increases upon 
the resumption of meiosis and continues to remain high until the metaphase/anaphase 
transition of meiosis I, after which it declines. Activity is increased again after polar-
body extrusion and remains high while the oocyte is arrested in metaphase II. Activity 
of MPF during the cell cycle is controlled both by the phosphorylation of p34 2 p and 
by the association of cyclin. The cyclin B subunit appears to be the major determining 
factor that controls the timing of events that take place during meiotic maturation. 
Ledan et al (2001) demonstrated that the rates of cyclin B synthesis and degradation 
were essential for this timing mechanism (Ledan et al. 2001). They found that by 
injecting cyclin B transcripts with poly A tails of different lengths into oocytes resulted 
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in disruption of meiotic progression. p342,  the enzymatic/catalytic subunit of MPF 
also known as cyc]in-dependent-kinase-1 (CDK1) is required for the resumption of 
meiosis after the temporary arrest at prophase I of meiosis. The phosphatases Cdc25a, 
Cdc25b and Cdc25c are activators of CDKI and they regulate cell-cycle progression in 
mitosis and meiosis as well as the DNA damage response. Female mice null for Cdc25b 
are infertile due to their oocytes remaining permanently arrested in prophase I because 
of the inability to active MPF (Lincoln et al. 2002). 
The mos proto-oncogene encodes a protein serine/threonine kinase and is required for 
the activation of MAPK. In the mouse oocyte, mos is required for metaphase II arrest 
and oocytes deficient in mos fail to arrest at metaphase II and undergo parthenogenetic 
activation (Colledge et at. 1994). Maturing oocytes from mos homozygous null mice 
mice fail to activate MAPK, while p34'2 kinase activation remained normal until 
metaphase where it decreased prematurely (Choi et at. 1996). Furthermore, in mos null 
oocytes the first polar body appears to be abnormally large and does not always 
undergo normal rapid degradation, and instead cleaved further. This suggested that 
mos is not only a cytostatic factor but is also required for regulating the size and 
degradation of the first polar body (Choi et al. 1996). The MOS/MAPK pathways has 
also been shown to responsible for correct spindle formation at metaphase I and 
metaphase II and repression of DNA replication at the metaphase I - II transition 
(Verihac et al. 1993; Colledge et al. 1994; Gebauer et al. 1994; Hashimoto et al. 1994; Araki 
et al. 1996). 
Gap junctions 
During fofficulogenesis, the oocyte and the surrounding granulosa cells communicate 
with each other occurs via gap junctions. Gap junctions are located at sites of close cell 
apposition and they function as intercellular membrane channels that permit the free 
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flow of inorganic ions, second messengers and small metabolites (Nicholson et at. 1997). 
Gap junctions are formed from connexin proteins, of which there are 15 different family 
members. Different connexin genes have different patterns of expression; some of 
which have are expressed ubiquitously and other have a more restricted pattern (White 
et at. 1999). In the mouse CONNEXIN 37 (CX37) and 43 (CX43) are two of the key 
connexins for gap junction formation during folliculogenesis. CX37 is expressed by the 
oocyte througout folliculogenesis. Mice null for CX37 were infertile due to follicle 
development failing at the pre-antral to antral transition stage (Simon etal. 1997). These 
oocytes could be rescued by treatment with okadiac acid (a protein phosphatase 
inhibitor) resulting in the initiation of meiotic maturation; however, on removal of 
okadiac acid the oocytes rapidly revert to an arrested state (Carabatsos et al. 2000). 
Additionally, oocytes from these CX37 animals appear to have retarded growth in the 
later follicles, indicating that heterologous gap junction communication is not only 
required for oocyte cytoplasmic maturation but also completion of oocyte growth 
(Carabatsos et al. 2000). Unlike CX37, homozygous CX43 targeted mice died during late 
gestation due to an essential function in heart development (Reaume et al. 1995). Some 
oocytes were present in the neonatal ovary but there appeared to be a considerable 
reduction in the original germ cell numbers (10% of normal) Ouneja et al. 1999). To 
circumvent embryonic lethality neonatal CX43 null ovaries were cultured in vivo and 
grafted to a kidney capsule allowing ovaries to be studied for a time period equivalent 
to three weeks after birth (Ackert et al. 2001). The results showed that in the absence of 
CX43 folliculogenesis arrested prior to the follicles becoming multilarninar, the 
suggested that the CX43 gap junction plays an indispensable role both in genn line 




The zona pellucida is a glycoprotein based matrix synthesised by the oocyte that 
separates the oocyte from the surrounding granulosa cells. The zona pellucida is first 
detected in primary follicles as patches of extracellular matrix. As oocyte growth 
continues, the zona pellucida increases in width from 3tm in the secondary follicle to 
7m in an early antral follicle. 
The zona pellucida is encoded by the products of three genes; Zpl, Zp2 and Zp3. 
Targeted inactivation at the Zpl, Zp2 and Zp3 loci have enhanced our understanding of 
the interaction of their gene products. Zpl null mice were able to form a zona pellucida 
with ZP2 and ZP3, though it is structurally flawed, and mice were fertile albeit severely 
reduced due to precocious hatching of early embryos (Rankin et al. 1999). Mice that 
lack Zp2 are infertile but were able to form a zona matrix early in oogenesis but it was 
considerably thinner than normal and did not persist in ovulated eggs (Rankin ci- al. 
2001). Mice lacking Zp3 are also infertile and completely unable to form any zona 
matrix even early in oogenesis like the Zp2 null line (Rankin Ct al. 1996). Oocytes 
isolated from each of the null lines can be matured and fertilised in vitro then cultured 
to the blastocyst stage. No live births resulted from the transfer of Zp2- and Zp3- null 
embryos to recipient females, though live pups were born from the transfer of Zpl- null 
embryos. These results suggested that only ZP3 is essential for formation of the zona 
pellucida. 	Furthermore, the morphological abnormalities observed during 
folliculogenesis of the Zp2 and Zp3 null animals adversely affect the developmental 
competence of the zona free oocyte. Importantly previous work has shown that 
artificial removal of the zona pellucida by biochemical means has no effect on 
development of the embryo (Naito ci- al. 1992). This may indicate that the 
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developmental defects associated with targeted inactivation of Zp2 and Zp3 are not 
only due to the physical absence of the normal zona pellucida matrix. ZPI, the least 
abundant zona pellucida protein, is thought to provide structural integrity to the zona 
pellucida since it is able to form inter-molecular disulphide bonds and cross link the 
ZP2 and ZP3 proteins (Green 1997). This would account for the functional properties of 
the zona pellucida remaining at low levels in Zpl null oocytes but the structure being 
disorganized. 
1.8 	Fertilisation 
For successful fertilisation of the ovulated oocyte the zona pellucida is required to 
mediate both the initial sperm-oocyte recognition and trigger the acrosome reaction. 
Originally it was believed that ZP3 was the primary sperm receptor that mediated 
recognition via the 0-linked oligosaccharide side chains (Bleil et at. 1980; Florman ct al. 
1985). More specifically, the oligosaccharides implicated were the terminal al,3 
galactose Bleil et al. 1988) and /or N-acetylglucosamine (Miller et al. 1992). Recently 
genetic studies have disputed this (Rankin et al. 1998). Furthermore, in mice that were 
unable to add the terminal a 1,3-galactose (Thall et al. 1995) or N-acetlyglucosamirte 
(Asano et at. 1997) residues due to a lack of the enzyme galactosyltransferase remained 
fertile. 
The recognition between the ovulated oocyte and the sperm appears to require species 
specific recognition. For instance, human sperm will not recognize mouse oocytes. 
Considerable research has been carried to ascertain if ZP3 has any involvement in 
recognition between the sperm and the oocyte. In homozygous null ZP3 oocytes that 
express recombinant human ZP3 the mechanical structure of the chimeric zona 
pellucida appeared normal but there was no change in the specificity of sperm binding; 
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mouse sperm bind and fertilise the oocyte and human sperm cannot (Rankin eL at. 
1998). Additionally, the human ZP3 expressed in these mice had the same motility on a 
SIDS-polyacrylamide gel as wildtype human ZP3 (64kDa) but this was distinctly 
different from the native mouse ZP3 protein (83kDa) (Rankin et at. 1998). This enforces 
the possibility that major post-translational modifications cannot convert the human 
ZP3 protein to mouse ZP3 protein. Clearly this cannot account for subtle post-
translation modifications and may suggest that other proteins other than ZP3 are 
required for sperm recognition. 
Immediately post fertilisation, the cortical granules that are located in the periphery 
enter the perivitelline space by exocytosis. This process results in biochemical 
modification of the zona pelluclia and this appears to prevent other sperm from binding 
and fusing with the oocyte's plasma membrane. The modifications involve cleavage of 
ZP2 is into several peptides of approximately 21-31kDa that remain bound to each 
other via disulphide bonds (Bleil et at. 1981). Currently, it is unclear whether the 
cleavage of ZP2 is causative or reflective for preventing polyspermy and if there are 
other factors involved. 
1.9 	Gene expression during oogenesis and early embryogensis 
During the growth phase of an oocyte, there are both qualitative and quantitative 
changes in key molecules involved in metabolism, structure and infonTnation. There are 
changes in cytoplasmic organelles such as the Golgi apparatus and mitochondria 
distribution (Gosden et at. 1997). In oocytes of small non-growing follicles very little is 
actually know about the transcriptional activity except that it is never completely silent. 
In contrast, once a follicle has been recruited for growth there is a dramatic up-
regulation of transcription and translation that is maintained until the oocyte reaches its 
full size. In the mouse, RNA syilthesis increases 300 fold to 15fg min-1 during peak 
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oocyte growth (Piko et al. 1982) and in the mature mouse oocyte there are 
approximately 0.3 - 0.5ng of RNA. On reaching fully size, mRNA synthesis in the 
oocyte virtually ceases and does not resume until 1 -3 days after fertilisation has 
occurred. 
At fertilisation, both the male and female genomes are transcriptionally silent and the 
earliest stages of embryogenesis rely on maternal components previously synthesised 
by the oocyte. As the embryo develops the maternal components decay and there is a 
switch to transcription from the zygotic genome. Embryonic gene transcription is first 
detected at a low level in the male pronucleus in the late one cell embryo (Bomio1 et al. 
1995). Major activation of the embryonic genome does not occur until the two cell stage 
(Schultz 1993), at this point maternal mRNA has degraded to such an extent that only 
30% of the total maternal mRNA remains. Given the key requirement of maternal 
proteins in early embryogenesis it is perhaps surprising that only a few maternal-effect 
genes have been identified in mammals. For instance, SPINDILIN (SPIN) is a maternal-
effect protein expressed for only a short specific time period. SPIN, associated with 
formation of the first meiotic spindle, is detected in unfertilized oocytes and two cell 
embryos but not in eight cell embryos (Oh et al. 1997). Another example of a maternal-
effect gene is Maternal Antigen That Embryos Require (MATER) (Tong Ct al. 2000). 
Female mice null for MATER are infertile; folliculogenesis, ovulation and fertilisation 
occur normally but embryos do not develop further then the two cell stage. In these 
embryos, transcription from the zygotic genome is initiated but become blocked at this 
point. Though the primer structure of MATER has been deduced, its' actual function 
during early embryogenesis remains unclear. 
The control of timing of translation and degradation of stored maternal mRNA in the 
oocyte has been studied intensely. Within this population there are pronounced 
differences in the translation timing for different genes; this appears to be timed to 
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some extent by physiological requirements. For instance genes such as ZP3 are 
translated along with cellular housekeeping genes throughout oogenesis. Others such 
as nzos and tissue-type plasminogen activator (tPA) involved in the cell cycle or at 
ovulation are not expressed until they are required later (Gosden 2002). The principle 
mechanism that controls masking-storage versus translational-degradation is selective 
cytoplasmic polyadenylation of mRNAs. Truncation of the pA tail masks the mRNA 
resulting in translational silencing, whereas extension produces activation. For 
instance, tPA normally has a tail length of - 250 pAs but when it is stored, and is 
transcriptionally inactive, the tail length reduces to 40 residues (Meric et al. 1996). 
This transcriptional silencing is likely to be brought about by a trans-acting repressor 
protein, which if displaced by a competitor transcript results in rapid elongation of the 
tail (Stutz et al. 1998). A higher level of control of expression may be brought about by 
physical masking of the transcripts' regulatory elements by ribonucleoprotein (RNP) 
particles (Matsurnoto et al. 1998) and/or interaction with cytoskeletal elements (Jansen 
1999). These mechanisms have the effect as to uncouple the synthesis and translation of 
RNA into protein and are likely to contribute to the long half lives and rapid 
degradation of maternal rnRNA in the oocyte. 
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1.10 The Cre-loxP tissue specific recombination system 
1.10.1 Background 









Targeted locus 	 1 	 2 
- 	 Cre recombinase mediated 
- - . 	 recombination 
Deletion of targeted locus 
h 	2 
Figure 1.4 Schematic illustration of the principle of gene inactivation by expression of Cre recombinase on a loxP floxed 
target sequence. A targeted locus is generated by homologous recombination between a loxP containing target vector 
and the genomic locus where the boxed regions 1 and 2 represent exons. The target DNA sequence is foxed, 
expression of Cre recombinase results in excision of this DNA sequence including exon 1 and the neomycin resistance 
cassette. The presence of the neomycin resistance gene (neoR) and diphtheria toxin (DT) allows for detection of ES cell 
clones that have undergone correct homologous recombination. 
Generation of mice with a targeted mutation of the gene of interest by homologous 
recombination has proven to be a highly successful approach for studying gene 
function (Brandon et al. 1995). A serious deficiency in this system concerns the time at 
which mice homozygous for the targeted mutation exhibit the phenotypic 
consequences. When mice heterozygous for the desired targeted mutation are crossed, 
homozygous offspring will suffer loss of gene function and hence loss of the 
corresponding protein expression from the time of conception throughout all tissues. 
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Due to this, mice homozygous for the mutation often die in utero where a gene product 
has a role(s) in embryonic viability (Lobe et al. 1998). Informative studies can be 
performed to identify why inactivation of a gene is lethal at that time, but functional 
analysis of the role of the gene later in development or in adulthood cannot be 
conducted. In other situations no apparent phenotype can be observed due to 
compensatory mechanisms, but this may in itself bring about unexpected phenotypes. 
A further complication is defining the gene function in a particular tissue. Where a gene 
is widely expressed non-tissue specific inactivation may ultimately result in a 
phenotype that is the combination of altering gene expression throughout the whole 
animal and not a specific tissue. 
One way of avoiding the issue of embryonic lethality is to use an approach that targets 
gene inactivation in a specific temporal and spatical manner during development. 
Tissue specific gene inactivation is most commonly achieved by combining 
homologous DNA recombination and the action of Crc (causes recombination events) 
site-specific DNA recombinase (Kuhn et al. 1997). Crc recombinase originates from the 
bacteriophage P1, and mediates recombination between specific 34bp DNA sequences 
named loxP sites. The loxP sequence consists of two 13bp inverted repeats interrupted 
by a 8bp palindromic sequence that defines the orientation of the site. Gene 
inactivation is achieved by deletion of a genomic region essential for gene function in a 
gene of interest. This is accomplished by introducing two loxP sites orientated in the 
same direction either side of the target genomic region (termed foxed). In the presence 
of Crc recombinase the foxed region is excised by Crc recombinase mediated 
recombination, as described in Figure 4. LoxP sites in opposing orientations result in 
inversion of the foxed sequences. 
The Cre-loxP system has been used to achieve tissue specific gene activation. Tissue 
specific gene inactivation by the Cre-loxP system is achieved by crossing two strains of 
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transgenic mice, one expressing Crc recombinase under a tissue specific promoter and a 
second harbouring a floxed target gene (Kuhn et al. 1997). LoxP containing mice are 
generated by conventional homologous recombination gene targeting approaches. 
Tissue specific Cre recombinase expression is generally achieved by a 'knock-in' 
approach, involving introducing a Crc recombinase cDNA or gene immediately 
downstream of a specific endogenous promoter that has the required spatial and 
temporal expression pattern. This system has been shown to function well in ES cells 
and in transgenic mice (Muller 1999). 
1.10.2 Specific spatial and temporal inactivation at the Oct-4 locus 
Homozygous Oct-4 null embryos do not develop further than the blastocyst stage due 
to the absolute requirement of Oct-4 for the identity of the pluripotent founder cell 
population (Nichols et al. 1998). As a result it has not been possible to investigate the 
role of Oct-4 in the germ cell lineage by this conventional gene targeting approach. 
Within the ISCR there are a number of transgenic mouse lines that could be used to 
address this issue by achieving specific spatial and temporal inactivation at the Oct-4 
locus using the Cre-loxP system, thus avoiding embryonic lethality. A floxed target 
allele of the Oct-4 gene (Niwa, H. unpublished) has been generated where loxP sites 
have been introduced flanking exons 2 and 5, this is illustrated in Figure 5. Two Crc 
recombination expression lines have been obtained where Crc recombinase is expressed 
by germ cells during their development and by oocytes during oogenesis; TNAP-Cre 
(Lomeli et al. 2000) and ZP3-Cre (Lewandoski et al. 1997) respectively. These are 




TNAP-Cre expression line 
The expression pattern of tissue non-specific alkaline phosphatase (TNAP) is well-
characterised (MacGregor et al. 1995). Targeting of a LacZ reporter construct to the 
TNAP genomic locus revealed that TNAP expression is first detectable at early E7 stage 
embryos in a small number of cells located within the extraembryonic mesoderm 
posterior to the primitive streak. Expression of TNAP is consistent with that published 
for germ cells; however at later stages of development expression is also detected in the 
intestine and spinal cord by E11.5. Furthermore, in E14 stage embryos expression is 
also detected within the developing skeletal system and the placenta. Published 
literature concerning the TNAP-Cre line (created by targeted integration of Crc into the 
TNAP locus) reports that when using the double Crc reporter line, lacZ/human alkaline 
phosphatase (Z/AP) (Lobe et at. 1999), approximately 60% of germ cells underwent 
recombination (Lomeli et at. 2000). 
ZP3-Cre expression line 
ZP3 is expressed in the zona pellucida of growing oocytes (Philpott et at. 1987; Dean et 
at. 1989). Experiments have been performed by Lira and colleagues who have 
identified the ZP3 regulatory region (Lira et at. 1990). A 6.5kb region within a 5' region 
adjacent ZP3 was sufficient to drive expression of a luciferase reporter construct in the 
expected ZP3 expression pattern. Using this regulatory region, a ZP3-Cre line has been 
generated by random integration of the construct (Lewandoski et at. 1997). Lewandoski 
and colleagues reported that the ZP3-Cre resulted in Crc-mediated recombination 
apparently occurring in 100% of oocytes of a foxed target gene. 
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Figure 1.5 Structure of Oct-4 transgenes and Cre expression constructs 
OCT-4 TRANSGENES 
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Oct-4 transgenes. The wildtype, foxed and null allele of Oct-4 are depicted above. Within the 
foxed Oct-4 locus, the location of loxP sites are indicated by the presence of filled triangles, the 
presence of Cre recombinase resulted in excision of this foxed region. Within the null Oct-4 
locus a STOP-SA-IRES-13-geo cassette has been introduced that replaces exons 2-5. SA = splice 
acceptor, IRES = internal ribosome entry site. 
CRE RECOMBINASE EXPRESSION CONSTRUCTS 
TNAP-Cre 
	 2kb 




ZP3 regulatory region 
	
CreORF 	p 
Cre expression constructs. The genomic structure of TNAP-Cre (Lomeli et al. 2000) and ZP3-Cre 
(Lewandoski et al. 1997) are depicted above. For the TNAP-Cre expression construct a Cre 
recombinase expression cassette has been introduced by homologous recombination into the 
TNAP locus. 	Exons are depicted by blue open boxes, grey shaded boxes represent the 
exogenous DNA sequence. Within the grey shaded regions; IRES = internal ribosome entry site, 
Cre = Cre recombinase and Neo-pA = a neomycin selectable marker and polyadenylation signal. 
The Z133-Cre cassette was generated by random integration. The 5' region of the Cre ORF has 
been modified to optimise translational efficiency and includes a nuclear localisation signal. The 
polyadenylation signal (pA) was derived from the human 3-actin gene. 
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1.11 Experimental strategy 
In order to investigate the consequence of the inactivation of the Oct-4 gene in germ 
cells and oocytes adult mice were required that contained both the floxed Oct-4 target 
allele and the appropriate Cre expression line. Due to the nature of the Cre-loxP system 
and the problems sometimes associated with efficiency of excision at the foxed target 
locus it is general practice to have just one foxed target allele. To achieve homozygous 
inactivation at the Oct-4 locus a second Oct-4 line was used where Oct-4 has been 
inactivated by conventional gene targeting approaches (Nichols et al. 1998). The 
genomic structure of the Oct-4 null allele is illustrated in figure 1.5. A general breeding 
scheme to generate animals of an Oct-4 -°" TNAP- or ZP3-Cre genotype is illustrated in 
Figure 1.6. More detailed information regarding the breeding schemes for each of the 
Cre recombinase expression lines is discussed in each of the results chapters. 
Oct-4 x Cre' 
Oct-4 Cre 	x Oct-4 IOXP/IOXP 
I 
Oct-4 Cre x wildtype 
Figure 1.6 Transgenic mouse breeding scheme. This breeding scheme results in the generation 




1.12 Aims and objectives 
This aim of this thesis was to cause targeted recombination of a floxed Oct-4 allele 
generating Oct-4 null germ cells and developing oocytes using two specific Crc 
recombiriase expression lines, TNAP-Cre (Lomeli et al. 2001) and ZP3-Cre (Lewandoski 
et al. 1997). Crc recombinase activity of each of the mouse lines was assessed by 
crossing to reporter lines. The consequence of Oct-4 inactivation in germ cells and 
oocytes was also investigated indirectly by analysing inheritance of the Oct-4 




Chapter 2: Materials and Methods 
2.1 	Materials 
Commonly used solutions were made according to Sambrook et al. (1989). All 
chemicals were of analytical grade and supplied by BDH or Sigma. Agarose (SeaKern 
LE agarose) for electrophoresis was obtained from Biowhittaker Molecular 
Applications (BMA). Restriction endonucleases were supplied by Roche and New 
England Biolabs. Synthetic oligonucleotides were supplied by Oswel DNA Service. 
Antibodies were obtained from BD Transduction Laboratories, Santa Cruz 
Biotechnology, Jackson IrnmunoResearch Laboratories or donated by individuals (see 
Table 2.2). 
Primers 
Primer sequence (5'- 3') 
Oct-4 null 1 TGACCGCTTCCTCGTGCTTTACG 
Oct-4 null 2 GCCTTCCTCTATAGGTTGGGCTCC 
Oct-4 null 3 GCTTATGATCTGATGTCCATCTCTGTG 
Oct-4 foxed 1 - GGATCCCATGCCCTCTTCTGGT 
Oct-4 foxed 2 AACCCCAGGTGATCTTCMAACAG 
Oct-4 recombined 1 GGATCCCATGCCCTCTTCTGGT 
Oct-4 recombined 2 GAGAAGAAGGCAGCCTTAGC 
R26R 1 AAAGTCGCTCTGAGTTGTTAT 
R26R 2 GCGAAGAGTTTGTCCTCAACC 
R26R 3 GGAGCGGGAGAMTGGATATG 
sGFP 1 CAGCAGCACGGGGCCGTCGCCGATGG 
sGFP 2 CCGGGGTGGTGCCCATCCTGGTCGAG 
TNAP-Cre 1 CACGTCGATGGCCGCTCTA 
TNAP-Cre 2 TMGGGCCAGCTCATTCCTCC 
ZP3-Cre 1 TGATGAGGTTCGCAAGAACC 
ZP3-Cre 2 CCATGAGTGAACGAACCTGG 




Primary Source 	 Secondary Source 
antibody antibody  
Oct-4 (N-19) Santa Cruz Biotechnology, Inc F1TC donkey a-goat Jackson ImmunoReseach 
IgG Laboratories 
Oct-4 (Oct-3) BD Transduction Laboratories 11  FITC rabbit a-mouse Molecular Probes 
IgG  
Stat-3 (C-20) Santa Cruz FITC goat a-rabbit Jackson ImmunoReseach 
IgG Laboratories 
Cre Gift from G. Schutz, German Cancer FITC goat a-rabbit Molecular Probes 
- Research centre IgG  
Table 2.2 Details of primary and secondary antibodies. 
Details of probes for in situ hybridisation 
Probe Linearise Transcribed Fragment Plamid Source 
size  
Cre (antisense) EcoRI T3 850bps pRCre Elena Tzouanacou, 
ISCR. 
Cre (sense) Clal T7 850bps pRCre Elena Tzouanacou, 
ISCR. 
Oct-4 EcoRI T3 470bps Oct-4 StuiStul (AGS Ian Chambers, ISCR. 
(antisense)  122)  
Oct-4 (sense) XhoI T7 470bps Oct-4 StuiStul (AGS Ian Chambers, ISCR. 
122)  




2.2.1 Maintenance of animals 
Mice were housed and bred within the animal unit at ISCR according to the provisions 
of the Animals Scientific Procedures Act 1986. Mice were maintained in a stabilised 
environment on a 12 hour light/12 hour dark cycle. 
2.2.2 Recovery of embryos 
To collect embryos at specific developmental stages, overnight matings were set up and 
the females examined for the presence of a vaginal plug on the subsequent morning. 
Noon on the day of finding a vaginal plug was designated EO.5. Embryos were 
dissected from the uterus in PBI. 
PB1 med/a preparation (for 520m/s), prepared by Frances Stenhouse. 
sodium chloride 4.110g 
potassium chloride 0.105g 
sodium phosphate 1.500g 
potassium dihydrogen orthophosphate O.lOOg 
glucose 0.520g 
sodium pyruvate 0.023g 
penicillin 0.030g 
UHP water 513.5mls 
CaCl2 (stock 1.617gI100rnl UHP water) 4.400mls 
MgCh (stock 3.131g/100ml UI-IF water) 1.600mls 
0.5% phenol red 1.000mls 
After the mixture was made, the solution was adjusted to a pH of 7.0-7.2 and sterilized through 
a 0.22 micron filter. 10% FCS was added to the final solution. 
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2.2.3 Induct/on of supero vu/at/on and collect/on of unfertilized oocytes 
Five week old female mice were injected intraperitoneally (IF) with 0.1mI of pregnant 
mare's serum (PMS) (50IUIml in 0.9% NaC1) followed by IF injection of 0.1rnl human 
chorionic gonadotropin (hCG) (501U/ml in 0.9% NaCI) 47 hours later. Superovulated 
unfertilised oocytes were dissected from the lumen of the oviduct and disaggregated 
from surrounding granulosa cells by treatment in hyluronidase solution (0.1% in 
HEPES-mCZB (H-mCZB) preparation, H-mCZB as described in Kirnura and 
Yanagimachi (1995) then rinsed with PBS. 
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2.3 	Molecular Biology 
2.3.1 Mouse/embryo genotyping 
Preparation of genomic DNA 
Ear punches were taken from three week old pups by the animal house staff according 
to the provisions of the Animals Scientific Procedure Act 1986. For embryos, tissue 
samples were taken from either the embryo itself or from the yolk sac, then rinsed three 
times in PBS (137mM NaCl, 2.7mM KC1, 10mM Na2PO4, 2mM KH2PO4 in dH20). 
Samples were incubated overnight in a shaking waterbath at 55°C in 50tl of embryo 
buffer (50mM KC1, 10mM Tris HC1 pH 8.3, 2.5 mM MgCl2, 0.45% Nonidet P-40 (NP-40), 
0.45% Tween-20) to which proteinase K had been freshly added (20jil of 20mg/rnl 
proteinase K per imi of embryo buffer). Samples were boiled for 10 minutes at 100°C 
prior to centrifuging at 13K in a bench top centrifuge for 10 minutes. DNA samples 
were stored at -20°C. 
Polymerase Chain Reaction (PCR) genotyping 
Typically 5tl of genomic DNA was added to a reaction containing 5 units of Taq 
(QIAGEN), 1/10 volume of lOx QIAGEN PCR buffer, 0.21nM dNTPs and lOOng of 
primer per reaction with the total reaction volume being made up to 30il with dH20. 
Primers sequences are detailed in table 2.1. PCR program cycles for genotyping each 
transgenic line are detailed in table 2.4. For the Oct-4 null PCR reaction, 400ng of 
primers 1 and 3, and 800ng of primer 2 were added to the reaction mix. 
PCR reaction products were subjected to electrophoresis in 2% (w/v) agarose gel 
containing 0.5g/ml ethidiurn bromide in 0.5 x TBE buffer (40mM Tris-borate, 2mM 
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EDTA). Table 2.5 details the sizes of the PCR reactions products. A 1kb DNA ladder 
(Gibco BRL) was used to estimate the size of the PCR products. DNA was visualised 





Hot start 95°C 2min45sec 
Denature 94°C 15sec 
Anneal 65°C 12sec x34 





Hot start 94°C 3mm 
Denature 94°C 30sec 	1 
Anneal 55°C 30sec 	x35 






95°C 2min 45sec 
94°C l5sec 
60°C 12sec x34 






94°C lssec 	1 
56°C Imin x35 







55°C 45sec 	x35 






94°C 15sec 	1 
55°C 12sec x34 
72°C 1mm 	J 
72°C 10mm 
4°C 
Table 2.4. PCR programmes for mouse/embryo genotyping. For all PCR reactions except Oct-4 
null, a Biometra Unoll machine was used. For the Oct-4 null PCR a Gene Amp PCR System 
9700 (Applied Biosystem) machine was used. On reaching 4oC samples were either run out on 
an agarose gel or stored at -200C. 
Oct-4 Oct-4 Oct-4 sGFP R26R TNAP- ZP3-Cre 
null 	floxed 	Rec. 	 Cre 
mut 	545bps 	358bps 	500bps 	520bp 	250bps 	262bps 	389bps 
Wt 	688bps 	324bps 	* * 500bps 	* * 
Table 2.5. PCR DNA product sizes for mouse/embryo genotyping. The * symbol indicates that 
no wildtype product was amplified in this reaction. 
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2.3.2 Whole mount RNA in situ hybridisation 
Whole mount in situ hybridisation were carried as detailed previously (Wilkinson D. C. 
1992). Embryo/tissues samples were fixed in 4% PFA overnight at 4°C. The samples 
were washed in PBS, then dehydrated through one change of 25%, 500/n  and 75% 
rnethanol:PBS, and finally in two changes of 100% methanol (5 minutes each wash, on 
ice). Embryos/tissue samples were then stored at -20°C. 
Embryos/tissue samples were rehydrated through 75%, 50%, 25% rnethanol:PBS then 
washed twice in PBT (5 minutes each wash, room temperature). Embryos/tissue 
samples were incubated in 10jg/ml proteinase K in PBT; E7.5-8.5 embryos were 
incubated for 7.0 minutes, E10.5 embryos for 20 minutes and genital ridges from E12.5 
embryos for 5 minutes. To inhibit the proteinase K activity the samples were incubated 
in glycine (2mg/ml in PBT), washed in FBI (2 x 5 minutes, room temperature) then 
refixed in 0.2% gluteraldehyde/4% PFA for 20 minutes. Samples were washed in PBT 
(2 x 5 minutes, room temperature) prior to incubating for 1 hour in prehybridisation 
solution (50% ultrapure formamide, 5 x SSC pH 4.5, 50ig ml heparin, 0.1% Tween 20) at 
70°C. Denatured probe (1:100 dilution) was added to the hybridisation solution (as 
prehybridisation buffer but additionally containing 100g/ml Torula yeast RNA, 
100ttg/ml of herring sperm DNA and probe). Embryo/tissue samples were incubated 
overnight in hybridisation solution at 70°C in a humidified chamber. 
The following morning the embryos/tissue samples were washed twice in solution I 
(50% ultrapure fonTnamide, 5x SSC pH 4.5, 1% SDS in dJ-120) for 30 minutes at 70°C, 
washed once in solution 1:11 (50% solution I: 50% solution Ii) for 10 minutes at 70°C then 
three times in solution II (0.5M NaCl, 10mM Iris pH7.5, 0.1% Tween 20 in dH20) for 5 
minutes at room temperature. The samples were then incubated twice in RNAase A 
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(100tgInil) in solution II for 30 minutes at 37°C. Washes were then performed once in 
solution II and solution III (50% ultrapure formamide, 2x SSC pH4.5 in dH:O) for 5 
minutes at room temperature prior to washing twice in solution III for 30 minutes at 
65°C. Embryos/tissue samples were washed three limes in TBST (lOx 1 .4M NaCl, 
27mM KC1, 0.25M Tris pH7.5, 1% Tween-20 in dH20; use at lx) for 5 minutes at room 
temperature, preblocked with 10% sheep serum in TBST for one hour at room 
temperature then incubated overnight at 4°C in a 1/2000 dilution of anti-DIG-AP FAB 
fragments (Boehringer) in TBST. 
The next day the embryo/tissue samples were washed in TBST (6x 1 hour) with the last 
wash continuing overnight at 4°C. Subsequently the samples were washed three times 
in NTMT (100mM NaCl, 10mM Tris pH9.5, 50 mM MgCh, 0.1% Tween-20 in dH20) for 
10 minutes at room temperature then incubated in 4.5tl NBT (Gibco/BRL), 3.5jd BCIP 
(Gibco/BRL)/rnl NTMT in the dark at room temperature until colour development was 
observed. The reaction was stopped by washing three times for 5 minutes PBS 
containing 1mM EDTA and the samples stored in 0.01% azide in PBS at 4°C 
All solutions were made up using 0.1% diethyl pyrocarbonate (DEPC) treated distilled 
water which was autoclaved prior to use. 
2.3.3 Preparation and labelling of digoxigenin labeled ant/sense riboprobe 
104g of plasrnid DNA was digested with the appropriate restriction endonuclease in a 
reaction mix containing 5 units of the appropriate restriction endonuclease (see Table 
2.3), 1/10 volume of appropriate buffer and dl-120 to a final reaction volume of 20041. 
This was incubated at 37°C for 2 hours. DNA was precipitated with 21/2 volumes of 
absolute ethanol and 1/10 volume of 3M sodium acetate, then centrifuged at 13K in a 
bench top centrifuge for 10 minutes. The DNA pellet was washed in 70% ethanol, 
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centrifuged briefly, the supernatant was removed and the pellet air dried at room 
temperature. The DNA pellet was resuspended in lOpJ of dH20. 1-3g of DNA was 
added to lOpi 5x NTP mix, 5il lOx transcription buffer, 50 units RNase inhibitor, 50 
units of appropriate phage RNA polymerase and dH20 to a final volume of 50d. This 
was incubated at 37°C for 2 hours. Subsequently 20 units of RNAase-free DNAase was 
added to the reaction mix and incubated at 37°C for 15 minutes. To stop the reaction 
4p1 of 2501-nM EDTA was added, then the DNA was precipitated using 5.5u1 of 4M LiC1 
and 165d of absolute ethanol and left at -70°C overnight. The following day the sample 
was centrifuged at 13K for 15 minutes at 4°C. The supernatant was removed, the pellet 
was washed in 70% ethanol then air dried before being resuspending in 100tl of dl-120. 
4-5tl of the probe was run out on 0.8% agarose gel to check for size and degradation. 
Prior to use an appropriate amount of probe was denatured at 95°C then immediately 
placed in ice before adding to prewarmed hybridization buffer. 
All solutions were made up using 0.1% diethyl pyrocarbonate (DEPC) treated distilled 
water which was autoclaved prior to use. 
2.3.4 Isolation of total RNA from animal tissues 
Total RNA was isolated from animal tissues using the RNeasy Midi protocol 
(QIAGEN). In brief, the tissue was homogenized and the lysate centrifuged at 13 000 
rpm for 5 minutes in a bench top microfuge. One volume of 70% ethanol was added to 
the supernatant, mixed by vortexing, then applied to the RNeasy midi spin column and 
centrifuged for 5 minutes at 13 000 rpm. The flow through was discarded and 3.8m1 of 
buffer RWI was added to the column followed by centrifugation for 5 minutes at 13 000 
rpm. The flow through was discarded and 2.5m1 of buffer REE was added to the 
column followed by centrifugation for 2 minutes at 13 000 rpm. This was repeated a 
second time but the centrifugation step was carried out for 5 minutes. To elute the 
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RNA 150d of RNase-free water was applied to the column and centrifuged for 3 
minutes at 13 000 rpm. This was repeated a second time. Eluted RNA was stored at - 
20°C. 
2.3.5 Reverie transcript/on PCR (RT-PCR) 
First -Strand cDNA synthesis 
First-Strand cDNA synthesis was performed as detailed in the SuperScriptTM First-
Strand Synthesis System for RT-PCR protocol (Invitrogen Life Technologies). In brief, 
to ltg of total RNA, 50ng of random hexamers and 1mM dNTP mix were added to 
DEPC treated water to a total volume of lOjil. Sample were then incubated at 65°C for 5 
minutes and incubated on ice for at least one minute. To each sample 2jil of lox RT 
buffer, 41.Ll of 25mM MgC12, 2il of 0.1M DTT and 1d of RNaseOUT Recombinant 
Ribonuclease Inhibitor were added. Samples were incubated at 25°C for 2 minutes, 
followed by addition of Iil (50 units) of SuperScriptTM II RT followed by a further 
incubation at 25°C for 10 minutes. Samples were then incubated at 42°C for 50 minutes. 
The reaction was terminated by incubation at 70°C for 15 minutes. Synthesised cDNA 
was stored at -20°C. 
PCR 
5p1 of the 1s1  strand reaction were used in a 30i1 PCR reaction set up as described earlier 
in section 2.3.1. Conditions for the primer pair 187/188 for amplification of Crc were as 
described earlier in Table 2.4. Primers for -actin were as follows: forward - 
GTGACGAGGCCCAGAGCAAGAG, reverse - AGGGGCCGGACTCATCGTACTC. 
For the 3-actin PCR reaction a hot start at 94°C for 5 minutes was carried out, followed 
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by a cycle of 94°C for 30 seconds, 58°C for 30 seconds, 72°C for 1 minute repeated 20 
times. Finally reactions were incubated at 72°C for 10 minutes and after reaching 4oC 
were either analysed or stored at 20°C. 13-actin PCR reactions were performed on a 




2.4.1 Preparation of paraffin sections 
Tissues samples were fixed in 4% PFA overnight at 4°C. The samples were washed in 
PBS and then dehydrated through 50%, 60%, 70%, 80%,  90% and 2 x 100% ethanol:PBS. 
Washes were carried out for 30 min at room temperature. Samples were cleared in 
xylene for 1 hour at room temperature before being placed in fresh in molten paraffin 
wax. The wax was changed three times and with 1 hour incubations. After cooling 
embedded tissue samples were stored at 4°C. 8pm sections were cut using a microtome 
(Anglian Scientific. 0325) and placed on poly-lysine coated slides (BDH). 
2.4.2 Eosin staining 
Wax sections were dewaxed in xylene for 10 min and rehydrated 100%, 95%, 70%, 50%, 
dH20 ethanol:dH20 (5 min each wash). Sections were stained for 4 min in 1% (w/v) 
eosin solution in dH20, washed briefly in dH20 prior to dehydration through 50%, 
70%, 95%, 100% ethanol:dll-120 (2 seconds each wash) then placed in xylene for 10 
minutes. Stained sections were mounted under a coverslip in DPX mountant. 
2.4.3 Staining embryos for 5-gal activity 
Embryos (E3.5 to E12.5) were fixed for 30 min to 2 hours depending on their size in 
fixing solution (0.2% glutaraldehyde, 2mM MgCl, 5mM EGTA, 0.1M phosphate buffer 
pH7.3) at 4°C and washed three times for 20 minutes in wash solution (0.1M phosphate 
buffer pH7.3, 2mM MgCl, 0.1% (w/v) sodium desoxycholate, 0.02% NP-40, 0.05% BSA) 
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at room temperature. Staining was performed at 37°C in the dark in wash solution 
containing 5mM K3Fe(CN)6, 5mM K4Fe(CN)6.H20 and 1mg/mi 5-bromo-4-chloro-3-
indoly 13  D-galactopyranoside (X-gal) (Sigma) for 2 hours to overnight. X-gal was 
originally dissolved in dimethyl formamide at a concentration of 50mg/mi. Following 
staining, specimens were refixed overnight in fixing solution and stored at 4°C. 
2.4.4 Staining of E12. 5 genital ridges for alkaline phosphatase activity 
Genital ridges were dissected from E12.5 embryos with fine forceps. The dissected 
tissue was washed twice in PBS for 15 minutes then fixed in 4% PFA for 2 hours. Fixed 
tissue was washed three times in PBT for 15 minutes and left overnight in 70% ethanol. 
The tissue was washed in dH2O (3 x 15 mm), incubated in Proteinase K solution 
(2.5!tg/rnl in dH20) for 3 minutes at 37°C then placed immediately in glycine (2mg/mi in 
dH20) for 15 minutes at room temperature. Prior to staining the tissue was washed in 
dH20 (3 x 15 minutes). Staining was performed at room temperature for 10 minutes in 
the dark as described by Ginsburg (1990) using the staining solution (1% sodium 
5'5'diethyl barbiturate, 0.12% MgC12, 0.02mg/mi a napthyl phosphaste, 1.0mg/mi fast 
red TR in dJ-120). Following staining, specimens were washed in dH20 (2 x 10 minutes) 





25.1 Whole mount antibody staining 
Oocytes were freed of their zona pellucida using acidified (pI-l5.2) Tyrodes medium 
(Hogan et a!, 1986), washed briefly in PBS/PVP (PBS containing 3mg/mi PVP) then 
fixed in 2.5% PFA for 15 minutes at room temperature. Fixed oocytes were 
permeabilised in 0.25% Trition 000 in PBS/PVP for 30 minutes then placed in blocking 
solution (0.1% BSA, 0.01% Tween 20 in PBS) for 15 minutes. Oocytes were incubated in 
primary antibody solution (blocking solution plus 10  antibody) for 1 hour. The anti 
Oct-4 (N-19, Santa Cruz; Oct-3, BD Transduction Labs) and anti Stat3 (Santa Cruz) 
antibodies was used at a 1:100 dilution. Subsequently the oocytes were washed three 
times with blocking solution for 15 minutes, incubated in an appropriate secondary 
antibody solution (blocking solution plus appropriate FITC conjugated 20  antibody at 
1/100) for 1 hour and rinsed three times in blocking solution prior to mounting in 
citiflour (Agar Scientific). 
2.5.2 Antibody stafriig of frozen sections 
Embryo/tissue were dissected then fixed in 4% PFA for 2 hours at 4°C and washed in 
PBS (3 x 5 minutes) prior to leaving overnight in 30% sucrose/PBS at 4°C. The 
embryo/tissue sample was embedded in OCT on dry ice and stored at -80°C. Prior to 
sectioning the embedded tissue/embryo samples were placed at 20°C for 30 minutes. 
10pm sections were cut using a cryostate (Lecia CM1900) and the sections were stored 
at -20°C. The sections were briefly allowed to air dry before washing quickly with PBS 
(5 x 2 minutes) at room temperature. The sections were blocked in PBTS (0.IM PBS, 
0.1% triton-X 100, 1% BSA) for 2 hours at room temperature, then incubated in a 
56 
Chapter 2 
humidified chamber from 1 hour to overnight with the primary antibody (Crc 1/100; 
Oct-4 (Oct-3) 1/100; Oct-4 (N-19) 1/100) diluted in PBTS. Subsequently the sections 
were washed with PBS (3 x 5 minutes) and incubated with the appropriate FITC 
conjugated secondary antibody (1/100) for 1-2hrs in the dark at room temperature, then 




Digital images of whole-mount embryos and sections were acquired using Openlab 
v.3.0 (Improvison) and a digital camera attached to a Zeiss Stemi SVI I stereoscope with 
bright field and FITC fluorescence optics. Acquired images were processed using 
Adobe Photoshop v.7.0 (Adobe Systems Inc.) 
Confocal microscopy and imaging was performed by Linda Sharp at the Division of 
Biomedical and Clinical Sciences within The University of Edinburgh. 
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Chapter 3: Investigation into achieving targeted inactivation at the foxed 
Oct-4 locus in germ cells using the TNAP-Cre line. 
3.1 Introduction 
The embryonic expression pattern of murine Oct-4 suggests that this transcription 
factor may be a germhne determinant in mammals. A proposed model is that Oct-4 is 
the "master" gene of the germline (Pesce and Scholer, 2000). It would be expected that 
if this was the case that Oct-4 would be both necessary and sufficient to form the 
germline from any pluripotent cell in the epiblast and be absolutely required for germ 
cell identity. Based on this hypothesis it would be expected that deletion of Oct-4 
protein in germ cells during their specification and development would result in their 
loss. To test if Oct-4 is required for germ cell identity a standard gene targeting 
approach cannot be undertaken because of early embryonic lethality at E3.5 (Nichols ef 
a!, 1998). One way of circumventing embryonic lethality is to use the Cre-LoxP system 
of conditional gene inactivation (see section 1.10.1). The Crc expression line TNAP-Cre 
has previously been shown to cause Crc mediated deletion in PGCs at E9.5 - El0-5 
using a Z/AP reporter, such that at E13 approximately 60% of germ cells in the genital 
ridge had undergone recombination (see section 1.10.2, Figure 1.5 and Lomeli et a!, 
2000). Using this transgenic line in combination with the floxed Oct-4 target gene and a 
null Oct-4 allele, mice were bred of the TNAPCre*/  Oct-4°' genotype. In these 
animals it was expected that recombination of the floxed Oct-4 target gene would occur 
in PGCs and allow investigation into the consequences of loss of Oct-4 in genii cells. 
The essential consideration for using the Cre-LoxP system to address a given biological 
question is the specificity, both spatially and temporally, of excision of the floxed target 
gene. This is critical where Oct-4 is to be targeted during germ cell development and 
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specification due to the fact that no reporter gene is activated on recombination of the 
floxed Oct-4 locus. Any failure of this system could potentially invalidate any results; 
for instance, in the situation where recombination occurred earlier or later than 
expected, occurred in a mosaic pattern or did not occur at all. In parallel to 
investigating spatial and temporal TNAP-Cre mediated deletion mice, were bred of the 
TNAP-Cre Oct-4- °" genotype and investigated for effects on germ cell number. These 
animals were also crossed to wildtype animals to investigate effects on fertility. 
This chapter investigates the spatial and temporal activity of the TNAP-Cre line and the 
consequence of using this Crc line to inactivate the floxed Oct-4 locus in TNAP-Cre 
Oct-4/l0 ' animals. 
3.2 	Experimental strategy 
To investigate the activity of the TNAP-Cre line, crosses to reporter lines were 
performed using floxed target genes that on recombination activated a reporter. The 
reporter lines used were a silent green fluorescent protein (sGFP) (Gilchrist Cf al. 2003) 
and the ROSAgeo26 (R26R) reporter line (Soranio et a!, 1999). Figure 3.1 shows the 
genomic structure of the sGFP and R26R reporter lines. 
Mouse crosses were performed to generate TNAP-Cre Oct-40'  embryos and animals. 
These animals were bred with wildtype animals to investigate their fertility and pups 
born were genotyped for the status of the foxed Oct-4 allele; recombined or not 
recombined. To investigate if excision of the foxed Oct-4 locus by TNAP-Cre caused 
any gross abnormalities in germ cell numbers alkaline phosphatase staining was 
performed on genital ridges dissected from E12.5 TNAP-Cre Oct-4—embryos. 
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non recombined: inactive 
SAPGK-neo 
recombined: active 
SA 	LacZ pA 
tpA 	LacZ pA 	ROSA 26 genomic region 
ROSA 26 genomic region 
Figure 3.1 Genomic structures of sGFP and R26R reporter lines. The sGFP line was generated 
by random integration of the indicated construct and consists of a floxed region containing of 
puromycin selection cassette (Puro pA) flanked by PKG4 promoter and GFP. The R26R was 
generated by targeting to the Rosa 26 locus and consists of a PGK neomycin selection cassette 
(PGK-neo tpA) flanked by the endogenous R26R splice acceptor and a 3-galactosidase 
expression cassette (LacZ pA). In the presence of Cre recombinase the foxed region in each 
reporter line was excised resulting in the expression of GFP or 3-galactosidase. 
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Figure 3.2 GFP expression in E7.5 embryos obtained from male sGFP x female TNAP-Cre 
crosses. Panels a, b and c show a double positive TNAP-Cre sGFP embryo. Panel c shows a 
close up image of the boxed region in panel b. A ThAP1sGFP embryo is shown in panels d 
and e. Embryos are shown under U.V and bright field. 
Figure 3.3 GFP expression in E10.5 embryos from male sGFP x female TNAP-Cre crosses. Panels 
a and b show a double positive TNAP-Cre sGFP+,L  embryo. Panels c and d show a TNAP-Cre 
sGFP" embryo. Embryos are shown under U.V and bright field. 
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Figure 3.4 GFP expression in genital ridges from E12.5 embryos from male sGFP x female mAP-
Cre crosses. Panels a, b, c, d and e show genital ridges from double positive TNAP-Cre sGFP 
embryos under light field and U.V. Panel e is a close up image of the boxed region in panel b. 
Panels f and g show a genital ridge from a wildtype embryo under light field and U.V. 
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R26R reporter fine stud/es 
A second reporter line, R26R, was employed due to the fact that given the intensity of 
the fluorescent relative to background auto fluorescence when using the sGFP reporter 
lines it was difficult to view any finer details of sGFP activation in the TNAP-Cre' 
sGFP' embryos. Mouse crosses were performed between the TNAP-Cre and the R26R 
lines. Whole E3.5, E7.5, E8.5, E10.5 and E12.5 embryos obtained, and where possible 
their yolk sacs, were stained for 13-galactosidase activity and genotyped by PCR (see 
Tables 3.2 and 3.3). Figure 3.5 shows images of embryos stained for 1-galactosidase 
activity obtained from male R26R x female TNAP-Cre crosses. Figure 3.6 shows 
images of embryo stained for 13-galactosidase activity obtained from male TNAP-Cre x 
female R26R crosses. 
The majority of the TNAPreR26R (21/60) stained throughout for 13-galactosidase 
activity, however, some embryos (6/21 TNAP-CreR26R embryos) exhibited a degree 
of mosacism where 13-galactosidase activity was restricted to patches of cells (see 
Figures 3.5b, c and d and 3.5a). These patches varied in size and position and did not 
correlate with the expected position of the germ cells. These results are discussed in 
section 3.4. TNAP-Cre activity was detected ectopically in TNAPCre*  R26R' 
embryos, from E3.5 (see figure 3.6a) onwards and f3-galatosidase activity was observed 
in the embryonic and extraembryonic regions, both throughout and in a mosaic pattern 
at E7.5 (see Figures 3.5 a, b and c). in later embryos at E8.5, E10.5 and E12.5 13-
galactosidase activity was detected throughout and a few mosaic embryos were 
observed (see Figures 3.5 and Tables 3.2 and 3.3). Genital ridges stained from TNAP-
Cre R26R E12.5 embryos did not show any difference in the level of staining than the 
rest of the embryo (see Figure 3.6c). Also staining was observed in the yolk sac for 
these embryos (see Figure 3.6d). Crosses were performed using both male and female 
TNAP-Cre heterozygotes to investigate the possibility of a TNAP-Cre maternal effect. 
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The data would indicate that there appears to be no apparent difference in TNAP-Cre 
activity depending on whether the allele was contributed maternally or paternally with 
this number of embryos. Furthermore, with this limited number of embryos the genetic 
background of the TNAP-Cre animals, either 129 or C57BL/6, does not appear to affect 
the phenotypic outcome. Overall a similar level of mosacism was detected for 
contribution of the TNAP-Cre allele paternally or maternally; 4/12 of TNAP-Cre 
R26R embryos were mosaic where the TNAP-Cre allele was contributed maternally 
and 2/9 of TNAP-Cre R26R embryos were mosaic where the TNAP-Cre allele was 
contributed paternally (see Table 3.2 and 3.3). 
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E7.5 male R26R 	x female TNAP-Cre 	(129) 
number genotype phenotype 
1 TNAP-Cre/R26R stained throughout embryonic and extraembryonic regions (see Figure 3.4a) 
2 TNAP-Cre7R26R stained throughout embryonic and extraembryonic regions (see Figure 3.4a) 
3 TNAP-Cre/R26R no staining observed (see Figure 3.4a) 
4 TNAPCre/R26R' no staining observed (see Figure 3.4a) 
E7.5 male R26R 	x female TNAP-Cre 	(131-6) 
1 TNAP-Cre'7R26R' patches of stained cells located on anterior side of embryo (see Figure 3.4b and c) 
2 TNAP-Cre'7R26R no staining observed (see Figure 3.4b and c) 
3 TNAP-Cre/R26R no staining observed 
4 TNAPCre7R26R* no staining observed 
E8.5 male R26R 1  x female TNAP-Cre 	(129) 
1 TNAP-Cre 17R26R mosaic patches of stained cells throughout embryo and yolk sac(see Figure 3.4d e) 
2 TNAP-Cre7R26R mosaic patches of stained cells throughout embryo and yolk sac 
3 TNAPCre+/R26R no staining observed (see Figure 3.4f) 
4 TNAP-Cre/R26R no staining observed 
5 TNAP-Cre7R26R no staining observed 
E10.5 male R26R 	x female TNAP-Cre 	(129) 
1 TNAP-Cre/R26R staining throughout embryo (see Figure 3.4g) 
2 TNAPCre*/R26R* staining throughout embryo 
3 TNAP-Cre/R26R no staining observed (see Figure 3.4g) 
4 TNAP-Cre/R26R no staining observed 
E10.5 male R26R 	x female TNAP-Cre' (131-6) 
1 TNAP-Cre/R26R stained throughout embryo (see Figure 3.4h) 
2 TNAP-Cre'7R26R stained throughout embryo 
3 TNAP-Cre/R26R 1  no staining observed (see Figure 3.4h) 
4 TNAP-Cre/R26R no staining observed 
5 TNAP-Cre7R26R no staining observed 
E12.5 male R26R 	x female TNAP-Cre 	(129) 
1 TNAP-Cre']R26R stained throughout embryo (see Figure 3.4i) 
2 TNAP-Cre'-/R26R stained throughout embryo in a mosaic manner (see Figure 3.4j) 
3 TNAP-Cre"7R26R' stained throughout embryo 
4 TNAP-Cre/R26R no staining observed (see Figure 3.4k) 
5 TNAP-Cre/R26R no staining observed 
6 TNAP-Cre/R26R no staining observed 
7 TNAP-Cre/R26R no staining observed 
8 TNAP-Cre/R26R no staining observed 
Table 3.2 Phenotypes and genotypes observed on analysis of embryos at [7.5, E105 and E12.5 
from male R26R' x female TNAP-Cre crosses. The TNAP-Cre lines were N3 backcrosses to 
129 and C57BL/6 (131-6). The R26R line was on a C57BL/6 background. 
Chapter 3 
Figure 3.5 J3-galactosidase staining of E7.5 (a,b and c), E8.5 (d, e and f), E10.5 (g and h) and 
E12.5 (i, J  and k) embryos obtained from male R26R' x female ThAP-Cre" crosses. The 
genetic background of the ThAP-Cre line is indicated. BL6 refers to a C57BL/6 background. 
 
a(129) 	 b(BL6) c(BL6) 
i d(BL6) 	 f(BL6) 
j(B k (BL6) --- 
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E3.5 male TNAP-Cre 1  (129) x female R26R 
number genotype phenotype 
1 TNAP-Cre'/R26R cells of half the blastocyst stained (see Figure 3.5a) 
2 TNAP-Cre'7R26R no staining observed (see Figure 3.5b) 
3 TNAP-Cre/R26R no staining observed 
4 TNAP-Cre/R26R no staining observed 
E7.5 male TNAP-Cre 	(129) x female R26R' 
1 TNAP-Cre/R26R' stained throughout embryonic and extraembryonic regions 
2 TNAP-Cre/R26R no staining observed 
3 TNAP-Cre/R26R no staining observed 
4 TNAP-Cre/R26R no staining observed 
E7.5 male TNAP-Cre 	(131-6) x female R26R 
1 TNAP-Cre'7R26R stained throughout embryonic and extraembryonic regions 
2 TNAP-Cre/R26R stained throughout embryonic and extraembryonic regions, appeared mosaic 
3 TNAP-Cre/R26R no staining observed 
4 TNAP-Cre/R26R no staining observed 
5 TNAP-Cre/R26R no staining observed 
E10.5 male TNAP-Cre 	(129) x female R26R 
1 TNAPCre/R26R' staining throughout embryo 
2 TNAPCre*/R26R no staining observed 
3 TNAP-Cre/R26R no staining observed 
4 TNAP-Cre/R26R no staining observed 
E10.5 male TNAP-Cre 	(131-6) x female R26R 
1 TNAP-Cre/R26R stained throughout embryo 
2 TNAP-Cre/R26R no staining observed 
3 TNAP-Cre/R26R no staining observed 
4 TNAP-Cre/R26R no staining observed 
5 TNAP-Cre7R26R no staining observed 
E12.5 male TNAP-Cre 	(129) x female R26R 1  
1 TNAP-Cre/R26R stained throughout embryo (see Figure 3.5c) 
2 TNAP-Cre'1-JR26R stained throughout embryo 
3 TNAP-Cre/R26R stained throughout embryo 
4 TNAP-Cre/R26R no staining observed 
5 TNAPCreh7R26R+ no staining observed 
6 TNAP-Cre/R26R no staining observed (see Figure 3.5c) 
7 TNAP-Cre 17R26R no staining observed 
8 TNAP-Cre7R26R no staining observed 
Table 3.3 Phenotypes and genotypes observed on analysis of embryos at E7.5, E10.5 and E12.5 
from male TNAP-Cre 1 x female R26R' crosses. The TNAP-Cre lines were N3 backcrosses to 
129 and C57BL/6 (131-6). The R26R line was on a C57BL/6 background. 
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Figure 3.6 3-gaIactosidase staining of E3.5 (a and b) genital ridges (c) and yolk sac (d) from 
E12.5 embryos obtained from male ThAP-Cre x female R26R crosses. The TNAP-Cre lines 
were N3 backcrosses to 129 and C57BL/6 (BL6). The R26R line was on a C57BL/6 background 
a (129) 	 b (129) 
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3.3.2 Targeted inactivation of the foxed Oct-4 allele using TNAP-Cre 
Mice/embryos of the TNAP-Cre Oct4-/loxP genotype were generated by the following 
crosses, as shown in Figure 3.7. 
TNAP-Cr&' x Oct-4' 
I 





TNAP-Cre' Oct-4-/'Oxp x wildtype 
TNAP-Cre 1 Oct-4+/loxp  
TNAP-Cre Oct 4-/IOxP 
TNAPCre+ Oct 4+/kxP 
Figure 3.7 Breeding scheme to generate TNAP-Cre" Oct-4' mice (denoted in red). The four 
genotypes from TNAP-Cre Oct-4 x Oct-4 loxP/IoxP  cross are indicated and theoretically would 
be expected to be obtained in a 1:1:1:1 Mendelian ratio. 
Investi'ation into a potent/al negative maternal effect of TNAP-Cre 
Given that ectopic TNAP-Cre recombmase mediated deletion occurred throughout the 
embryo at the sGFP and R26R reporter loci this could also be anticipated at the foxed 
Oct-4 locus. Work in progress by J. Nichols in Austin Smith's group using a T-Cre line 
that was active in the epiblast to inactivate the foxed Oct-4 locus has shown that Oct-4 
in the epiblast is required for normal development. Due to this potential overlap in 
expression patterns between the TNAP-Cre and T-Cre lines crosses were performed 
between TNAP-Cre'- Oct-4 and Oct-4 '°"°" animals, to firstly identify if the 
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appropriate mutant embryos were obtained, and secondly if they were obtained in the 
expected numbers based on the chi-squared calculation where x2 = 	 ((observed - 
expected)2/expected). Furthermore, y values were also calculated to ascertain if the 
maternal or paternal contribution of the TNA P-Crc allele caused any deviation from the 
expected Mendelian ratio of 1:1:1:1. 
On analysis of the genotypes of 112 embryos from 16 litters a x2 value of 2.5 was 
calculated (Figure 3.8, Table 3.4). With 3 degrees of freedom, at p:!~0.05, x2 value = 7.82. 
Therefore the calculated x2 value suggests the data is in agreement with a Mendelian 
ratio of 1:1:1:1. A x2 value of 1.80 was calculated for 77 embryos from 11 litters where 
the TNA P-Crc allele was contributed paternally (Figure 3.9, Table 3.5). Therefore the 
calculated x2 value suggests the data is also in agreement with a Mendelian ratio of 
1:1:1:1. However, a x2 value of 11.29 was calculated for 35 embryos from 7 litters where 
the TNAP-Crc allele was contributed maternally (Figure 3.10, Table 3.6). Thus the 
genotypic ratio is significantly different from the expected Mendelian outcome. 
Furthermore, if resorbtions are assumed to represent embryos of the TNAP-Cre Oct-4-
'lox" genotype and the x2 values recalculated all x2 values are nonstatistically significant 
and are in agreement with the predicted Mendelian ratio of 1:1:1:1. The x2 values 
calculated were as follows; x2 = 3.00 for all embryos, x= 3.50 where the TNAP-Crc allele 
was contributed paternally and x2 = 4.35 where the TNAP-Crc allele was contributed 
maternally. 
These data may suggest that some of the TNAPCre*/. Oct4/b0x' embryos where the 
TNAP-Cre allele was contributed maternally were lost daring embryogenesis. 
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Total E12.5 embryo genotypes from 




TNAP-Cre' ThAP-Cre TNAP-Cre TNAP-Cre' resoptions 
Q4 (oF 	04*/xP 	04-oxP 	Oct-4+"Oxp  
Embryo genotype 
Figure 3.8 Distribution of embryo genotypes from total TNAP-Cre Oct-4 x Oct-4 	I 'O-P  
crosses. TNAP-Cre Oct-4-l'-p embryos are indicated in red. 9 resoptions were also recorded. 
Genotype observed number expected number (observed - expected)2/expected 
TNAP-cre' Oct-4 0 26 28 0.14 
TNAP-Cre 	Oct-4+/1OxP 27 28 0.04 
TNAPCreOct-4 35 28 1.75 
ThAP-CreOct-4" 24 28 0.57 
total= 112  2-25 
Table 3.4 Calculation of x2  value for total embryo genotypes from the TNAP-Cre Oct-4 x Oct-
oxp/IoxP cross where x2  = E ((observed - expected)2/expected). 
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Embryo genotypes from 





E lo LIiui. 
TNAP-Cre 	TNAP-Cr&' TNAP-Cre' TNAP-Cre resoptions 
Oct-4 ! 04/1OxP 	OCt4d' 	Oct-4 
Tibryo genotype 
Figure 3.9 Distribution of embryo genotypes from male TNAP-Cre Oct-4 1  x female Oct-4 
oxpfIoxP crosses. 3 resoptions were also recorded. 
Genotype observed number expected number (observed - expected)2/expected 
TNAPCre*Oct_4fb 24 19.25 1.17 
TNAP-Cre 	Oct 4*/IoP 18 19.25 0.08 
TNAP-CreOct-4 19 19.25 0.00 
TNAP-Cre0ct-4 16 19.25 0.55 
total = 77  x2 = 1.80 
Table 3.5 Calculation of x2  value for embryo genotypes from the male TNAP-Cre Oct-4 1  x 
female Oct-4 10xPI10xP cross where x2 = ((observed - expected)2/expected). 
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Embryo genotypes from 








I—M-, -M - 
TNAP-Cre' TNAP-Cre' resoptions 
04-/1OXP Oct-4 
Embryo genotypes 
Figure 3.10 Distribution of embryo genotypes from male Oct-4 	1' 	x female TNAP-Cre 
Oct" crosses. 6 resoptions were also recorded. 
Genotype observed number expected number (observed - expected)2/expected 
TNAP-Cr&1 Oct-4-/'Oxp 2 8.75 5.21 
TNAP-Cre 	Oct-4+lbxp 9 8.75 0.01 
TNAP-CreOct-4 16 8.75 6.01 
TNAPCre/Oct4d' 8 8.75 0.06 
total = 35  = 11.29 
Table 3.6 Calculation of x2  value for embryo genotypes from the male Oct-4 
IoxP/IOxP  x female 
TNAP-Cre Oct-4 1 where x2 = ((observed - expected)2/expected). 
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Germ cell staining in TNAP-Cre Od4//oxP embryos 
Alkaline phosphatase is expressed by germ cells and therefore can used as a marker to 
look for gross abnormalities in germ cell numbers within E12.5 genital ridges. Alkaline 
phosphatase staining was performed on genital ridges dissected from E12.5 embryos 
from TNAP-Cre'- Oct-4 x Oct410'/b0xl'  crosses. Tissue samples were taken from all 
embryos for PCR genotyping and this data has been presented in the previous section. 
No apparent difference in staining was obvious between genital ridges from TNAP.-
Cre Oct-4°' embryos and the other three embryo genotypes (TNAP-Cre'- Oct-4°'', 
TNAP-Cre Oct-4- °'1' and TNAP-Cre Oct-4°'), see Figure 3.11. This would suggest 
that mice of the TNAP-Cre'- Oct-4°'' genotype had no severe reduction in germ cell 
numbers. 
Male TNAP-Cre Oct-4 x female Oct-4'-xP/ $OxP  
a( JW - . 
. 
TNAP-Cre Oct4fb 	TNAP-Cre Oct4+hb0  TNAP-Cre-/- Oct-4"1"xP TNAP-Cre' Q4+/IOXP 
Female TNAP-Cre' Oct-4' x male Oct41010 
ci? f( ) 	1 h"  
TNAP-Cre Oct-4' 	TNAP-Cre' Oct-4 	TNAP-Cre Oct-4' 	TNAP-Cre 1 Oct-44' 
Figure 3.11 Alkaline phosphatase staining of E12.5 genital ridges from embryos from INAP- 
Cre 	Oct-4" x Oct-4 IbXP  crosses. Embryo genotypes are indicated; a-d are genital ridges 
from male TNAP-Cre Oct-4-1' x female Oct4i0x0  cross and e-h are genital ridges from 
female TNAP-Cre' Oct-4 x male Q 410XP/IOXP cross. 
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In vestigation into the inheritance pattern of the foxed Oct-4 allele 
Adult male and female TNAPCre*/ Oct-4" mice were crossed with wildtype animals 
to investigate if there were any affects on fertility and to analyse the status of the floxed 
Oct-4 allele in any pups born. Eight breeding pairs were set up (five male TNAP-Cre"- 
Oct-4-/',,xP and five female 	 animals) and all produced litters, the 
average litter size being 8. 121 pups born were genotyped by PCR from ear punch 
samples. On analysis of the genotypes of these 121 pups a x2 value of 2.81 was 
calculated (Table 3.7). With 3 degrees of freedom, at p!~ 0.05, Z2 value = 7.82. A x? value 
of 4.25 was calculated for 59 pups where the TNAP-Crc allele was contributed 
paternally (Table 3.8). A z2 value of 5.76 was calculated for 62 pups where the TNAP-
Crc allele was contributed maternally (see Table 3.9). None of these values were 
statistically significant and are in agreement with obtaining the expected genotypes in a 
1:1:1:1 Mendelian ratio. 
Table 3.10 surnrnarises the overall genotype results and includes the recombination 
status of the floxed Oct-4 allele; non-recombined, fully recombined or mosaic 
recombination. Tables 3.11 and 3.12 show the pup genotype results depending whether 
the TNAP-Crc allele was contributed maternally or paternally. The data suggest that in 
pups that have inherited the floxed Oct-4 allele recombination only occurs where 
TNAP-Crc is also inherited. If recombination did occur it was normally in a mosaic 
pattern. However, two pups were obtained where the TNAP-Cre allele was contributed 
maternally in which the Oct-4 foxed allele had undergone complete recombination. 




Genotype observed number expected number (observed - expected)2 /expected 
TNAPCre+0ct410P 26 30.5 0.60 
TNAPCre* Oct40' 32 30.5 0.10 
TNAP-Cre 1Dct-4 26 30.5 0.60 
TNAP-Cre0ct-4 37 30.5 1.51 
total = 126  = 2.88 
Table 3.7 Calculation of x2  value for pup genotypes from total TNAP-Cre" Oct4/10  x wt 
crosses where x2  = ((observed - expected )2  /expected). 
Genotype observed number expected number (observed-  expected)2/expected 
TNAPCre+Oct4+hI0P 12 14.75 0.51 
TNAP-Cre 	04+/IOxP 10 14.75 1.53 
TNAP-CreOct-4 17 14.75 0.34 
TNAP-CreOct-4 20 14.75 1.87 
total = 59  = 4.25 
Table 3.8 Calculation of x2  value for pup genotypes from male TNAP-Cre Oct-4-/'-p x female 
wt crosses where x2  = ((observed - expected )2  /expected). 
Genotype observed number expected number (observed - expected )2/expected 
TNAPCre+/Oct40F' 14 15.5 0.15 
TNAP-Cre 	Oct 4+fl=P 22 15.5 2.73 
TNAP-CreOct-4 9 15.5 2.73 
TNAP-cre'Dct-4' 17 15.5 0.15 
total = 62  x2 = 5.76 
Table 3.9 Calculation of x2  value for pup genotypes from female TNAP-Cre Oct-4°' x male 
wt crosses where x2  = ((observed - expected)2/expected). 
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pup genotype number recombination status of foxed Oct-4 allele 
non-recombined fully recombined mosaic 
26 13 2 11 
TNAP-Cre 	04*/xP 32 32 0 0 
TNAP-Cre 	0ct-4 26 - - - 
TNAP-Cre0ct-4 37 - - - 
Table 3.10 Total pup genotypes from TNAP-Cre Oct-4 ° x wt crosses. 
pup genotype number recombination status of floxed Oct-4 allele 
non-recombined fully recombined mosaic 
TNAP-creoct-4 °  12 7 0 5 
TNAP-Cre 	04+/bxP 10 10 0 0 
TNAP-Cr& 	Oct-4 17 - - - 
TNAP-CreOct-4 20 - - - 
Table 3.11 Pup genotypes from male TNAP-Cre Oct-4-/"'xp x female wt crosses. 
pup genotype number recombination status of foxed Oct-4 allele 
non-recombined fully recombined mosaic 
14 6 2 6 
TNAP-cre' 04+/kxP 22 22 0 0 
TNAP-Cre 	Q4 1  9 - - - 
TNAp-creoct-4' 17 - - - 
Table 3.12 Pup genotypes from female TNAP-Cre Oct-4-/"xp x male wt crosses. 
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1 2 3 4 5 6 7 8 9 '- -ye 
TNAP-Cre 	396bP 	 - - 	 mutant: 398bps 






1 2 3 4 5 6 7 8 9 	•' -ye 
4+jIOXP 
NR 	
396bps 	 mutant: 358bps 344bps N_I_I 	wildtype 34bps 298bps 
1 2 3 4 5 6 7 8 9 	+ -ye 
04+IIopR 	506bps 	 —' 	mutant: 500bps 
Figure 3.12 Example of typical genotyping data obtained from pups born from TNAP-Cre Oct-
4-/IoxP animals. The PCR product sizes are indicated for each reaction and the reaction conditions 
(see Figure 2.2) and primers (see Table 2.1) were as described in the materials and methods in 
Chapter 2. NR refers to non recombined and R refers to recombined at the floxed Oct-4 locus. 
Pup 
number 





1 No Yes No No TNAP-CreOct-4 
2 No Yes No No TNAP-Cre'_Oct-4 
3 Yes Yes No No ThAPCre*/_Oct-4 
4 Yes No Yes Yes TNAPCreFOct-4*/IoxPR 
5 No No Yes No TNAP-Cre 1_Oct-4 
6 Yes No Yes Yes TNAP-Cre _Oct-4 
7 Yes No Yes No TNAP-Cre _Oct-4' 
8 No No Yes No 
9 Yes No Yes Yes ThAP-Cre _Oct-4 
Table 3.13 Summary of genotype data from Figure 3.12 
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3.3.3 RT-PCR analysis of genital ridges from TNAP-Cr?" embiyos for the presence 
of Cre recombinase 
A Cre recombinase RT-PCR was performed on E12.5 genital ridges from TNAP-Cre 
embryos to identify whether or not Cre recombinase mRNA was present. No Cre 
recombinase RNA was detected, see Figure 3.13 below. The 3-actin control shows that 
RNA and cDNA was successfully isolated and generated for all samples, for the Cre 
recombinase RT-PCR an amplified product was only detected in the positive ES cell 
control treated with reverse transcriptase (RT). 
TNAP-Cre+ TNAP-Cre- ES +Cre ES -Cre 
+RT -RT +RT -RT +RT -RT +RT -RI -ye 
506bps 
Cre Cre recombinase 
	







Figure 3.13 Cre recombinase RT-PCR on E12.5 genital ridges from ThAP-Cre 1  embryos. For the 
embryo samples genital ridges were pooled from four positive and four negative TNAP-Cre" and 
TNAP-Cre1  embryos respectively. Samples were incubated with and without reverse 
transcriptase (RI). Positive and negative controls were obtained from an ES cell line that 




The results from both of the reporter line studies indicated that TNAP-Cre mediated 
deletion was not confined to germ cells as would be expected based on earlier 
publications (Lomeli et at. 2000; McGregor et at. 1995). instead TNAP-Cre mediated 
deletion occurred throughout embryo and extraembryonic regions and was detectable 
in an E3.5 blastocyst. This data would suggest that ectopic TNAP-Cre expression first 
causes Crc mediated recombination of the reporter loci during early embryogenesis. 
Once activated in a given cell the reporter loci continually express either GFP from the 
sGFP reporter or -galactosidase from the R26R reporter. The earlier in embryogenesis 
excision occurs the more cell lineages would be expressing GFP or -galactosidase 
throughout. 
Analysis of genital ridges from E12.5 TNAP-Cre sGFP' embryos where the TNAP-Cre 
allele was contribute maternally did shown that in 2/4 double positive embryos there 
appeared to an elevation of fluorescence in cells within the genital ridge. This could be 
explain by the possibility that the early TNAP-Cre mediated deletion occurring in the 
early embryo was mosaic but gave the appearance of fluorescence throughout the 
embryo later in development. In the embryos that showed an elevation in levels of 
fluorescence in cells within the genital ridge the germ cells may have undergone 
TNAP-Cre mediated recombination at the expected time. The elevated level of 
fluorescence may be due to more cells in a given region, i.e. the genital ridges, 
expressing GFP as a result of recombination occurring in a less mosaic manner than 
earlier in development. This may indicate that in these two particular embryos Crc 
was expressed in the genital ridges. However, due to the fact that 2 other embryos in 
the litter of the same genotype did not show this apparent elevation of fluorescence in 
the genital ridges indicates that the expression pattern of TNAP-Cre was not consistent. 
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Mosaic TNAP-Cre mediated deletion also occurred in a number of cases and the 
pattern did not reflect that which was expected for developing/migrating germ cells. 
No difference was apparent on either the genetic background or whether the TNA P-Crc 
allele was contributed maternally or paternally. This may be due to the small number 
of embryos used in this study. Furthermore, the presence of embryos which exhibited 
mosaic TNAP-Cre mediated deletion could not be attributed to particular male/female 
TNAP-Cre'- parental animals. The presence of mosaic and non mosaic embryos in the 
same litter suggest stochastic differences in TNAP-Cre activity between embryos in the 
same litter that are independent of the original parental allele. 
Male and female mice of the TNAP-Cre'- Oct-4- °' genotype were generated 
successfully. Analysis of embryos generated from the TNAP-Cre l/- Oct-4-11 x Oct-40 1 '> 
cross suggested that there was a significant loss of embryos of the TNAP-Cre '- Oct4x1' 
genotype where the TNAP-Cre allele was contributed maternally. However a number 
of adult TNAP-Cre Oct-4°' mice and embryos were obtained where the TNAP-Crc 
allele was contributed maternally indicating these mice/embryos can be viable. The 
data from the reporter studies indicates that TNAP-Cre causes Crc mediated deletion at 
the reporter loci in the 1CM and epiblast. If this pattern of excision occurred at the 
floxed Oct-4 locus is would be expected that the TNAP-Cre Oct-4' embryos would 
be non viable due to the absolute requirement for Oct-4 in the 1CM and epiblast for 
normal development. The results may suggest that TNAP-Cre exhibits a different 
excision pattern at the Oct-4 locus as compared to the reporter lines. For instance, if 
TNAP-Cre mediated recombination at the Oct-4 locus occurs at a low level in a mosaic 
manner such that the majority of TNAP-Cre Oct4-/i0xJ'  embryos are unaffected and can 
compensate for the loss of a few 1CM or epiblast cells. The loss of TNAP-Cre Oct-4-/IoxP  
embryos could be accounted for by TNAP-Cre mediated deletion at the Oct-4 locus 
occurring in some embryos at a higher frequency. Differences in recombination 
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frequencies at the foxed Oct-4 locus could be related to stochastic differences in TNAP-
Cre activity. 
Breeding of TNAP-Cre'- Oct-4 '°' mice with wildtype animals showed that these 
animals exhibited normal levels of fertility based on their litter sizes. Analysis of the 
status of the Oct-4 floxed allele (either recombined or non recombined) in pups born 
showed that if recombination at the foxed locus did occur it occurred in a mosaic 
pattern in those pups that also contained the TNAP-Cre allele. This would suggest that 
recombination occurred post fertilisation and was not related to the status of the 
originating parental germ cell. No pups were obtained that had undergone total 
recombination at the foxed Oct-4 locus and were negative for TNAP-Cre indicating 
that no pups could have been derived from an Oct-4 null germ cell. Recombination at 
the floxed Oct-4 locus was not detected in all 	 pups. This may be 
due to the nature of the biopsy for genotyping where an ear punch sample was used. It 
was conceivable that if other tissues of the TNAP-Cre 	 pups had been 
analysed recombination at the foxed Oct-4 locus may have been detected. 
Staining of genital ridges from E12.5 TNAP-Cre Oct-40x' embryos for alkaline 
phosphatase activity showed there were no gross abnormalities in germ cell number. 
Taken independently there could be three reasons for this; (i) Crc was not expressed in 
germ cells and no excision of the floxed Oct-4 locus occurred thus the germ cells 
maintain Oct-4 expression; (ii) Crc is expressed in germ cells at an earlier point in 
development and non recombined germ cell (i.e. Oct-4-°' NR)  were able to repopulate 
the genital ridges, or (iii) deletion of Oct-4 occurred in germ cells and Oct-4 is not 
required for germ cell identity. However, considering the data from the reporter 
studies and the inheritance pattern of the recombined Oct-4 foxed allele this suggested 
that TNAP-Cre mediated deletion activity is not what would be expected based on 
previous publications (Lomeli et al. 2000; McGregor et al. 1995) and may instead occur 
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very early in embryogenesis at the floxed Oct-4 locus in a variable mosaic manner. To 
identify if TNAP-Cre mediated deletion was likely to have occurred in germ cells in the 
genital ridge it was necessary to elucidate if Crc was expressed in germ cells in the 
genital ridge. Attempts to use an anti-Crc antibody and Crc in situ probe were 
inconclusive. RT-FCR of genital ridges isolated from E12.5 TNAP-Creembryos did 
not detect Crc recombinase mRNA. This would suggest that germs cells present in the 
genital ridges of the TNAP-Cre Oct-4" animals/embryos had not undergone 
recombination and remained Oct-4'° NR5O  could still express Oct-4. If Crc 
recombinase was expressed earlier in the germ cells during there migratory period it 
was highly likely that the non recombined germ cells (i.e. Oct4 oxJNR) were able to fully 
repopulate the genital ridges by normal mitotic division. The recombination observed 
at the floxed Oct-4 locus was likely due to ectopic TNAP-Cre mediated deletion in the 
early embryo at a low frequency to permit TNAP-CreOct-4°' embryos to be viable. 
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Chapter 4: Investigation into achieving targeted inactivation at the floxed 
Oct-4 locus in oocytes during oogensis using the ZP3-Cre line. 
4.1 Introduction 
Detailed analysis of the expression pattern of Oct-4 during oogenesis by Pesce, M and 
colleagues (1998) showed that Oct-4 was dramatically downregulated as oocytes 
entered the first meiotic division followed by a burst of Oct-4 expression in the final 
stages of meioc prophase I. This had led to speculation that the downregulation of 
Oct-4, which occurs in both sexes, may represent one of the molecular triggers involved 
in the commitment to meiosis (Pesce, M etal. 1998). The upregulation observed in 
oocytes as they exit prophase I has been suggested to indicate an involvement of Oct-4 
in oocyte growth and/or acquisition of meiotic competence (Pesce etal. 1998). 
To investigate if Oct-4 is involved in oocyte growth or meiotic competence by 
inactivating the Oct-4 gene a standard gene targeting approach cannot be undertaken 
because of early embryonic lethality at E3.5 (Nichols et a!, 1998). One way of 
circumventing embryonic lethality is to use the Cre-LoxP system of conditional gene 
inactivation (see section 1.10.1) to inactivate the Oct-4 gene prior to the burst of Oct-4 
expression as the oocyte exits meiotic prophase I. This burst first occurs at 12 -14 dpp 
in the first cohort of oocytes exiting meiotic arrest and undergoing meiotic maturation; 
this burst in Oct-4 expression will be repeated in all oocytes exiting meiotic arrest 
throughout the reproductive life of the mouse. In order to generate null Oct-4 oocytes 
the Cre-LoxP system employed must cause deletion at the foxed Oct-4 locus before the 
first burst of Oct-4 expression at 12-14dpp. 
The expression pattern of Zona Pellucida 3 (ZP3) expressed by the oocyte during 
oogenesis has been well characterised (Philpott et al. 1987), see Figure 4.1. Analysis of 
RN 
Chapter 4 
the developmental expression of ZP3 during oogenesis by in situ hybridisation showed 
that ZP3 mRNA was first detectable in oocytes 20m in diameter (early growth phase), 
and significant accumulation occurred as the oocyte grew peaking at 220fg (0.1 - 0.2% 
of total p(A-) RNA) in 50trn oocytes. A dramatic decline in expression was detected 
once the oocytes had reached 60 - 65m in diameter that coincided with the latter stages 
of growth and meiotic maturation. Ovulated eggs were found to contain very low 
levels of ZP3 mRNA; this mRNA represented no more than 0.04% of total mRNA and 
did not appear to be translated. Northern blot analysis of ZP3 expression in ovaries 
showed that ZP3 transcripts were first detected in ovaries from 1-2dpp (approximately 
10 - 20 m in diameter) mice, reaching a maximal level in ovaries from 9dpp 
(approximately 35tm in diameter) mice and by 15dpp (approximately 50tm in 
diameter) has decreased to 50% of the maximal levels. Further work using the 
upstream region of the ZP3 gene to drive a luciferase reporter construct showed that 
luciferase activity increased substantially during the first 21 days after birth, peaking at 
approximately 18dpp (Lira Ct al. 1990). 
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oocyte 	 oocyte 
20iim in "50tm in in 
diameter 	 diameter 	1 meiotic (3 
primary 	 division 
oocyte (2N) + meiotic arrest (4N) 	+ K—A 
3 d—I  'J) 
ovulated egg 	2nd meiotic 
I 	 I 	(2N) "50 gm division: 
I in diameter 	occurs at fertilisation 
I 	 birth 	 I 
I 	Resting oocytes (10jm in diameter) do not contain detectable amounts of 
I 	 ZP3 transcript but on entering their 
growth phase ZP3 transcripts rapidly 




I 	 I 
I 	 I 
Oct-4 expression 
I 	 I 
+ + 
16.5dpc 	 1 dpp 	12-14 dpp 
Down-regulation In all 
developing oocytes 	 At ldpp a low level of Oct-4 expression is detectable in all 
developing oocytes. 
At 12-14 dpp dramatic up-regulation of Oct-4 in the firs 
cohort of developing oocytes stimulated to complete meiosis. 
This up-regulation is coincident with completion of prophase I 
and marks exit of growth arrest. Very low levels of Oct-4 
protein are detectable in the unfertilised egg. 
Subsequently, oocytes stimulated to exit growth arrest exhibit 
a dramatic up-regulation in Oct-4 expression. This occurs at 
different times for different oocytes subject to when a 
particular oocyte is selected to exit growth arrest and 
continues throughout the reproductive life of the mouse. 
Figure 4.1 Schematic illustration of the timing of Oct-4 expression in relation to ZP3 mRNA 
expression. 
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The Cre expression line ZP3-Cre has previously been shown to be specific to growing 
oocytes from the early stages of oogenesis and cause recombination of a target foxed 
gene at a very high efficiency of 100% (Lewandoski et al. 1997) (see section 1.10.2). The 
upstream control region used to drive Cre expression by ZP3 was the same as that used 
to drive expression of the luciferase reporter as discussed previously. Using ZP3-Cre in 
combination with the foxed Oct-4 target gene and a null Oct-4 allele mice were bred of 
the ZP3-Cre Oct4-1ld'  genotype. In these animals it was expected that recombination 
of the foxed Oct-4 target gene would occur in the diploid primary/early oocyte 
onwards, thus generating oocytes that were null for Oct-4, and allow investigation into 
the consequences of loss of Oct-4 during oogenesis. Figure 42 summaries the 
genotypic status at the Oct-4 locus at the chromosomal level as oogenesis proceeds. 
During oogenesis it is expected that recombination at the foxed Oct-4 locus will occur 
generating Oct-4 null oocytes. 
Ist polar 	 2nd polar\ 
body body 
primordial 	oogonium 	 primary 






(2N) 	 (2N) 	 (4N) 	 (2N) 	 (IN) 
Oct-4' 	 Oct-4" 	 04-/loXP 	 Oct-4' 	 Oct-4- 
Oct-4-/"p or or 
04IoXP/1oXP 	 Oct-4'0)9  
Figure 4.2 Summary of the genotypic status at the Oct-4 locus at the chromosomal level during 
oogenesis. Extrusion of the 2 polar body occurs at fertilisation so the oocyte does not exist as 
a true iN status, it is indicated here to show that the Oct-4 locus in the oocyte will either be 
Oct-4 or 04nuII 
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Similarly to the previous chapter, where TNAP-Cre was used to direct recombination at 
the floxed Oct-4 allele, the use of the ZP3-Cre line requires analogous considerations. 
Since this is a Cre-loxP based approach for achieving spatial and temporal gene 
inactivation one essential consideration is the specificity of the system. In parallel to 
investigating the temporal and spatial ZP3-Cre mediated deletion, female mice were 
bred of the ZP3-Cre Oct4-11oxI' genotype and crossed to wildtype animals to investigate 
effects on fertility and inheritance pattern of the foxed Oct4 allele (either recombined 
or non-recombined) in any pups born. 
This chapter investigates the spatial and temporal activity of the ZP3-Cre line and the 
consequence of using this Crc line to inactivate the floxed Oct-4 locus during ongenesis. 
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4.2 	Experimental strategy 
To investigate the activity of the ZP3-Cre line crosses to sGFP and R26R reporter lines 
were performed. Recombination at these loci resulted in activation of the reporter gene 
resulting in the expression of GFP or -galactosidase respectively. The genomic 
structures are shown in Figure 3.1. 
Mouse crosses were performed to generate ZP3-Cre Oct-4' embryos and animals 
(see Figure 4.8). These animals were bred with wildtype animals to investigate their 
fertility and pups born were genotyped for the status of the foxed Oct-4 allele; 
recombined or not recombined. 
4.3 Results 
4.3.1 ZP3-Cre reporter studies 
sGFP reporter ilnes stud/es 
Mouse crosses were performed between male ZP3-Cre and female sGFP line to 
generate double heterozygous female offspring where ZP3-Cre activity was confined to 
developing oocytes. Oocytes were examined from whole and disaggregated ovaries 
under UN light using a benchtop microscope and by confocal microscopy. Figure 4.3 
shows whole ovaries from ZP3-Cre sGFP and ZP3-Cre-,"- sGFP mice under UN and 
bright field. Bright green spherical dots were observed throughout double positive 
ovaries (see Figure 4.3 a), which were presumed to be the oocytes. However, in both 
wildtype and mutant ovaries there was a degree of background fluorescence which 
precluded vision. Vibratome sections were cut of these ovaries but background 
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autofluorescence precluded vision and also fixing the tissue in 4% paraformaldehyde in 
order to section it severely affected the levels of fluorescence. This was improved by 
viewing disaggregated non-fixed ovaries by confocal microscopy and demonstrated 
that GFP activity was always confined to the oocytes and not the surrounding tissue. 
Full grown oocytes, approximately 80tm in diameter, were brightly fluorescent 
throughout whereas less mature oocytes, approximately 40tm in diameter exhibited a 
lower degree of fluorescence. Figure 4.4 shows confocal images of disaggregated 
ovaries from ZP3-Cre sGFP'- and ZP3-Cre-' sGFP' mice. 
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Figure 4.3 Images of whole ovaries from ZP3-Cre sGFP' (a and b) and ZP3-Cre/sGFP' (c 
and d) six week old female mice under U.V light and bright field. The scale bar represents 
0.5mm. 
Figure 4.4 Confocal images of disaggregated ovaries from ZP3-Cre 1  sGFP (a, b and c) and 
ZP3Cre+sGFP (d and e) six week old female mice. The scale bar represents lOOi.tm. 
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ZP3-Cre' R26R 	 ZP3-Cre' R26R 
Figure 4.5 3-galactosidase stained superovulated oocytes from ZP3-Cre R26R' (a) and ZP3' 
R26R (b) female mice. The oocyte marked with the arrow took a few hours longer to stain 
than the other oocytes but it did appear slightly abnormal in appearance due to the larger than 
average zona pellucida. 
Mouse genotype Number of oocytes 3-galactosidase staining 
Zp3-Cre 	R26R 17 (1 mouse) All stained (1 took a few hours longer than others) 
ZP3-Cre' R26R 14 (1 mouse) none stained 
ZP3Cre*/ R26R 15 (1 mouse) none stained 
ZP3-Cre' R26R 30 (2 mice) none stained 
Table 4.1 Number of 3-galactosidase stained superovulated oocytes from ZP3-Cre R26R, 
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Figure 4.6 7im serial sections through 3-galactosidase stained 21dpp ovary from a ZP3- 
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Figure 4.7 7.im serial sections through 3-galactosidase stained 21dpp ovary from ZP3-Cre1  
R26R' mouse. Sections were counterstained with eosin. The scale bar represents 100 pm. 
Mouse genotype Total number of oocytes (> 
20im) in 10 x 7m sections 
Number of stained oocytes (> 20i.im) 
in 10 x 7m sections. 
ZP3-Cre 	R26R 
1 20 20 
2 18 18 
3 23 23 
4 35 35 
5 17 17 
ZP3-Cre' R26R 
1 17 0 
2 22 0 
Table 4.2 Number of stained individual oocytes in 7jm serial sections from 3-galactosidase 
stained ovaries from five ZP3-Cre R26R and two ZP3-Cre 1  R26R' 21dpp female mice. 
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4.3.2 Targeted inactivation of the foxed Oct-4 allele using ZP3-Cre 
Female mice of the ZP3-Cre' Oct-4°" genotype were produced by the following 
breeding scheme, as shown in figure 4.8. To generate female mice that will only exhibit 
ZP3-Cre activity in their ovaries a male ZP3-Cre' Oct-4 has to be crossed with a 
female Oct-4 l0xP/10xP  The reverse cross could have resulted in targeted recombination 
occurring throughout the pups of a ZP3-Cre' Oct4" genotype due to ZP3-Cre 
activity in the oocyte at fertilisation (Lewandoski et a!, 1996). 
ZP3-Cre x Oct-4+/- 
male ZP3-Cr&' ()4+/ 
female ZP3-Cre 1 Oct-4+/- 
male ZP3-Cre O 
genotypes 	female ZP3-Cre 1 Oct4 
produced from 
previous cross 	male ZP3Cre+  Oct-4+/- 
female ZP3-Cret Oct-4+/- 
male ZP3-Cret Oct-4 
female ZP3-Cre1 Oct-4" 
x female Oct-4 '-P/'-p  
female ZP3-Cre 
male ZP3-Cre Oct-4" 
female ZP3-Cre Oct-4" 
genotypes 	male ZP3-Cre" Oct-4" bxp 
produced from 
previous cross female ZP3-Cre Oct-4-/lcxp  
male ZP3-Cre 04-/kxP 
female ZP3-Cre1 04+/10xP 
male ZP3-Cre 04+/l0xP 
x male wildtype 
Figure 4.8 Breeding scheme to generate female ZP3-Cre Oct-4 bxP  mice (denoted in red). 
The four genotypes from male ZP3-Cre" Oct-4" x female Oct-4 "bxp cross are indicated and 
theoretically would be expected to be obtained in a 1:1:1:1 ratio. Female ZP3-Cre 1 Oct-4 
would be expected to be obtained 1/8. 
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Investigation into the inheritance pattern of the foxed Oct-4 allele 
Adult female ZP3-Cre Oct4/b0' animals were crossed with wildtype animals to 
investigate if there were any effects on fertility and to analyse the status of the floxed 
allele in any pups born. 
Female ZP3-Cre Oct-4 71°' mice were all fertile and 77 pups/embryos were born from 
12 females giving an average litter size of 6.4 pups. Pups/embryo genotypes from this 
cross would be expected to follow a 1:1:1:1 Mendelian ratio of the following genotypes; 
ZP3-Cre Oct-4- , ZP3-Cre'- Oct-4, ZP3-Cre-'- Oct-4 and ZP3-Cre- Oct-4. On 
analysis of the genotypes of these 77 pups/embryos a x2 value of 5.35 was calculated 
(Figure 4.9, Table 4.3). With 3 degrees of freedom, at p0.05, x2 value = 7.82. Therefore 
the calculated x2 value is in agreement with the expected 1:1:1:1 Mendelian ratio. No 
effect was observed on litter size with increasing age of the female ZP3-Cre Oct-4/', , 
mice. It may have been expected that if ZP3-Cre caused recombination at the fluxed 
Oct-4 locus in oocytes post the initial burst at 12-14dpp oocytes undergoing maturation 
later in the reproductive life of the mouse may have been effected. 
Furthermore, it would be expected that in these pups there would be a 1:1 ratio 
between those animals that had inherited the floxed Oct-4 allele and those that had 
inherited the Oct-4 null allele from the parental female mouse. On analysis of the Oct-4 
null or Oct-4 foxed recombined genotypes of the 77 pups/embryos a x2 value of 4.68 
was calculated, see Table 4.5. With 1 degree of freedom, at p:!~O.OS, x value = 3.84. This 
value indicates that there is a significant difference (i.e. there is only a 5% chance that 
the calculated x2 value would occur by chance) between the obtained and expected 
ratio and may suggest the loss of a proportion of oocytes where recombination at the 
floxed Oct-4 locus has occurred during oogensis. However, this is unlikely to be a true 
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result because it would be expected that if Oct-4 null oocytes are not viable both Oct-4- 
and Oct-4 	R oocytes would be lost simultaneously post recombination at the foxed 
Oct-4 locus (see Figure 4.2). The numbers obtain may reflect the relatively small 
number of animals/embryos in this study and the possibility of genotyping errors. 
Analysis of the status of the foxed allele showed that in all pups, irrespective of 
whether or not ZP3-Cre was present, the floxed allele was always recombined (see 
Table 4.4). No mosacism was observed. Recombination was not observed in 37 pups 
obtained from female ZP3-Cre-/- Oct-4-/I,xP mice when crossed to wildtype males; 18 ZP3-
Cre' Oct- and 19 ZP3-Cre Oct-4'. An example of typical genotyping data is 
shown in Figure 4.10 and Table 4.6. 
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Pup/ embryo genotypes from fenIe '3- 
Cre' Oct40x) x male wt crosses 
30 
ZP3-Cre 1 	ZP3-Cre 	ZP3-Cre 	ZP3-Cre' 
Oct-4 +/IoxP Oct-4+11-- p Oct-4+1- Oct-4+1- "
Pup/ embryo genotypes 
Figure 4.9 Distribution of pup/embryo genotypes from female ZP3-Cre Oct-+"Oxp x male wt 
crosses. No resorbtions were recorded for the embryo data. 
Genotype observed number expected number (observed - expected)2/expected 
ZP3-Cre 	04*/IP 16 19.25 0.55 
ZP3-Cre Oct-4° 13 19.25 2.03 
ZP3-Cre'Oct-4' 22 19.25 0.40 
ZP3-CreOct-4' 26 19.25 2.37 
total = 77  x2 = 5.27 
Table 4.3 Calculation of x2 value for embryo genotypes from the female ZP3-Cre Oct-4-"Oxp x 
male wt cross where x2 = ((observed - expected)2/expected). 
Genotype number recombination status of floxed Oct-4 allele 
non-recombined fully recombined mosaic 
ZP3Cre Oc 41 16 0 16 0 
ZP3-Cre' Oct-4~1'-p 13 0 13 0 
ZP3-CreOct-4" 22 - - - 
ZP3Cre /Oct4*i 26 - - - 
Table 4.4 Total pup genotypes from female ZP3-Cre1 Oct4110 x male wt crosses. 
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Phenotype observed number expected number (observed - expected)2/expected 
Qç4*IhxP 29 38.5 2.34 
Oct-4 48 38.5 2.34 
total = 77 x2  = 4.68 
Table 4.5 Calculation of x2  value for original oocyte genotypes from the female ZP3-Cre Oct-4 
IIoxP x male wt cross where x2 = ((observed - expected)2/expected). 









1 2 3 4 5 6 7 8 9 
0ct-4"0 NR 	396bps 	 mutant: 358bps 
344bps  
wildtype: 324bps 298bps 
1 2 3 4 5 6 7 8 9 +' + -ye 
Oct4b0xJ R 	506bps 	 mutant: 500bps 
Figure 4.10 Example of typical genotyping data obtained from pups born from ZP3-Cre Oct-4-
"' females crossed to wt males. The PCR product sizes are indicated for each reaction and the 
reactions conditions (see Figure 2.2) and primers (see Table 2.1) are as described in the 
materials and methods in chapter 2. NR refers to non recombined, R refers to recombined. 
Control DNA was obtained from stock mouse lines. 
Pup 
number 





1 No Yes No No ZP3-cre 	Oct-4+/- 
2 No Yes No No ZP3-Cre Oct-4+1- 
3 No Yes No No zp3-cre' Oct4* 
4 Yes No No Yes ZP3-cre 	Oct-4 +/JOxPR 
5 No No No Yes ZP3-cre' 04*/bxPR 
6 Yes Yes No No ZP3-cre 	Oct-4+1- 
7 No No No Yes ZP3-cre 04+/1oxPR 
8 No Yes No No ZP3-Cre' Oct-4+/- 
9 No Yes No No ZP3-cre' Oct-4+1- 




The results from the reporter line studies indicate that ZP3-Cre mediated deletion 
occurred in oocytes during oogenesis. Recombination at the sGFP locus was detectable 
in 40tm oocytes, which corresponded to a time at which the oocyte would be growing 
during early to mid meiotic arrest. Considerable background auto fluorescence 
prevented detailed investigation into the activation of the sGFP locus by the ZP3-Cre 
allele so a second reporter was employed; R26R, that on Crc mediated recombination 
expressed -galactosidase. Superovulated oocytes from ZP3-Cre R26R'- female mice 
all stained positively for -galactosidase indicating that ZP3-Cre mediated deletion was 
occurring prior to the point of ovulation at this reporter locus. The time point of ZP3-
Cre activity was critical to this study due to the fact that a burst of Oct-4 expression 
occurs as the oocyte re-enters the meiotic cycle which first occurs at 12-14 dpp in female 
mice. Analysis of f3-galactosidase activity in sectioned ovaries from 21dpp mice 
showed that R26R reporter activity was present in the majority of oocytes and 
detectable in oocytes from 20tm in diameter. This size of oocyte corresponded to 
oocytes in the early growth phase at the beginning of meiotic arrest. 
Female ZP3-Cre' Oct_4-/l0xl' mice were fertile and analysis of the inheritance pattern of 
the floxed Oct-4 allele (either recombined or not recombined) showed that all pups born 
that had inherited the Oct-4 floxed allele had undergone recombination. No mosacism 
was detected indicating that the recombination has occurred in the oocyte prior to 
fertilisation or in the one cell embryo. The information from the reporter line studies 
suggested that ZP3-Cre mediated deletion on the reporter loci occurred during the 
meiotic arrest period. Therefore these results may indicate the Oct-4 is not required 
during oogenesis. However, due to the fact that no direct information was known 
about the exact time of ZP3-Cre mediated deletion at the foxed Oct-4 locus and that 
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Cre mediated deletion can vary between target loci the results from the reporter studies 
may not necessarily reflect the time of the Crc mediated deletion at the floxed Oct-4 
locus. Furthermore, it was not possible to deduce whether or not Oct-4 protein or 
inRNA were present in oocytes of mutant ovaries due to inconclusive results using 
anti-Oct-4 antibodies and an Oct-4 in situ probe. Analysis of the genotypes of pups 
born from ZP3-Cre' Oct40>d'  females showed that pups were obtained of the expected 
genotypes in a 1:1:1:1 Mendelian ratio but the inheritance of either the floxed 
recombined or Oct-4 null allele was not in a 1:1 Mendelian ratio possibly suggesting the 
loss of some Oct-4° recombined oocytes. This cannot be the case since loss of the 
recombination at the floxed Oct-4 allele would generate 0ct_4/hb0 recombined oucytes that 
if not viable would result in their loss, i.e. loss of both Oct-4 and Oct-41 Inxed recombined 
alleles, see Figure 4.2. 
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Chapter 5: Discussion 
Embryonic expression data of the pattern of muririe Oct-4 suggests this transcription 
factor may be a gerrnline determinant. A hypothesis has been proposed where Oct-4 is 
the "master" gene of the germline (Pesce and Scholer, 2000). Based on this hypothesis it 
would be expected that Oct-4 would be necessary to form the germline from any of the 
pluripotent cells in the epiblast and be absolutely required for germ cell identity. As 
such, deletion of Oct-4 protein in germ cells during their specification and development 
would result in their loss by death or possibly somatic differentiation. Furthermore, 
Oct-4 is also expressed during oogenesis. Expression is dramatically downregulated 
when oocytes are meiotically arrested during prophase I of the first meiotic division but 
on exiting meiotic arrest, a dramatic burst of Oct-4 expression occurs suggesting that 
Oct-4 may have a role in the oocyte growth and/or acquisition of meiotic competence 
(Pesce et cii, 1998). If this is case, it may be expected that oocytes null for Oct-4 protein 
may be non viable and unable to complete meiotic maturation and/or undergo 
successful fertilisation. 
The objective of this study was to investigate the role of Oct-4 in the mammalian germ 
line using a Cre-LoxP approach. Two tissue specific Cre expression lines were used, 
TNAP-Cre (Lomeli et a!, 2000) and ZP3-Cre (Lewandoski et cii, 1997) that expressed Cre 
in germ cells and during oogenesis respectively. In combination with an Oct-4 floxed 
line and a null Oct-4 line, mice were generated of a TNAP- and ZP3- Cre Oct-4- '°' 
genotype. These mice were analysed for the consequences of Cre mediated deletion at 
the foxed Oct-4 locus in germ cells and in oocytes. Unfortunately complications 
regarding the temporal and spatial expression of the TNAP-Cre expression Erie 
prevented definitive conclusions being reached on the role of Oct-4 in germ cells. 
The pattern of TNAP-Cre and ZP3-Cre mediated deletion was inferred from the use of 
two reporter lines, sGFP and R26R, to indicate the Cre spatial and temporal deletion 
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pattern. This was due to the fact that a reporter cassette was not incorporated into the 
floxed Oct-4 locus. However, it has been that reported the recombination efficiencies 
for Crc recombinase can vary between target loci (Nagy 2000); Muller, U. 1998) such 
that Crc mediated deletion by TNAP-Cre and ZP3-Cre at the reporter loci may not 
reflect that at the floxed Oct-4 locus. 
5.1 	Consequences of TNAP-Cre mediated deletion at the foxed Oct-4 locus. 
Activation of dormant reporter lines showed that ectopic TNAP-Cre activity was 
detected in preimplantation embryos as opposed to being confined to the germ cells 
later during development. Analysis of TNAP-Cre'-Oct-4° adult mice that were 
expected to lack Oct-4 in their germ cells were fertile and E12.5 embryos of the same 
genotype had no severe apparent defects in germ cells numbers in their genital ridges. 
Pups born from these animals exhibited a mosaic pattern of inheritance of the 
recombined/non-recombined allele indicating that Crc mediated deletion occurred post 
fertilisation in these pups and not as a result of deletion in the germ cells. No pups 
were born that could be attributed to originate from an Oct-4 null germ cell. In 
conclusion mosaic ectopic TNAP-Cre mediated deletion in the early embryo is likely to 
account for recombination at the foxed Oct-4 target allele. Furthermore, no Crc 
recombinase was detected in genital ridges from E12.5 TNAP-Cre embryos. These 
results are discussed below. 
TNAP-Cre exhibited ectopic mediated deletion in the early embryo onwards for both 
reporter line studies. The presence of mosaic and non mosaic embryos in the same 
litter suggest stochastic differences in TNAP-Cre activity between embryos in the same 
litter that are independent of the original parental allele. It is well reported that 
differences in genetic background can have widely differing effects on the phenotype 
observed for both naturally occurring and targeted mutations (Muller, 1999). The two 
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genetic backgrounds used were 129 and C57BL/6 for establishment of TNAP-Cre lines 
and animals were bred for only three generations (N3). Mixing of genetic backgrounds 
was required to breed TNAP-Cre Oct-4°' mice. The published TNAP-Cre mouse 
line (Lomeli et cii, 2000) was on a 129 ICR M background. The differences in genetic 
background may account for the ectopic activity of the TNAP-Cre line used in this 
study due to the presence or absence of allelic variant of genes, referred to as modifier 
loci (Muller, 1999). Lomeli and colleagues did report a degree of ectopic TNAP-Cre 
mediated deletion, this manifested in mosaic expression throughout the embryo which 
was enhanced if the TNAP-Cre allele was maternal in origin (Lomeli et cii, 2000). 50% of 
embryos analysed did exhibit restriction of reporter line expression in the PGCs at E9.5 
- 10.5 (Lomeli et cii, 2000). 
From the reporter studies it was clear that the TNAP-Cre line exhibited early ectopic 
mediated deletion but it was not apparent whether or not Cre was expressed in the 
germ cells. RT-PCR analysis of E12.5 genital ridges from TNAP-Cre embryos showed 
that no Cre recombinase mRNA was detectable. Given that approximately 20 000 germ 
cells were present in each genital ridge and the RNA was made from eight pooled 
genital ridges there might not have been enough Cre cDNA to amplify and visualise for 
this reaction even if the Cre mRNA was at a low level. Also Lomeli and colleagues did 
not state whether or not they had analysed the germ cells at this or any point for actual 
Cre mRNA, instead they used reporter line studies to assay for activity (Lomeli et cii, 
2000). This approach would only identify when Cre mediated deletion first occurred 
and does not relay information as to whether or not Cre was expressed, and causes 
recombination, later during development. Analysis of the TNAP-Cre Oct-4 1° mice 
would support Cre not being expressed in the genital ridges. Alkaline phosphatase 
staining of germ cells in E12.5 genital ridges from TNAP-Cre Oct-4°>1' embryos 
demonstrated there were no gross abnormalities in germ cell number and also these 
animals showed normal levels of fertility. The efficiency of recombination by the 
Chapter 5 
TNAP-Cre line was found to be approximately 60% at the Z/AP reporter loci (Lomeli et 
al, 2000). If Crc was expressed earlier but expression not maintained by PGCs in the 
genital ridge, it would be likely that if sufficient numbers of non recombined germ cells 
remained they may be able to compensate for any loss of null Oct-4 germ cells since 
whilst migrating and on reaching the genital ridge they continue dividing; mitotic 
division ceases at E16.5. The inheritance pattern of the floxed Oct-4 allele (either 
recombined or non recombined) in pups born from TNAPCre*  Oct-4"°' adult mice 
showed that if recombination did occur it occurred in a mosaic pattern and only where 
TNAP-Cre had also been inherited. This suggests that the recombination at the floxed 
Oct-4 locus did not occur in the germ cells but was due to early ectopic Crc mediated 
deletion in the embryo. 
A further observation regarding the TNAP-Cre line was that maternal inheritance of 
the TNAP-Cre allele in TNAP-Cre Oct-4°' embryos resulted in a significant loss of 
some embryos of this genotype. Oct-4 is absolutely required in the 1CM (Nichols et al, 
1998) and the epiblast for normal development unpublished, J Nichols). Given the 
potentially variable Cre mediated deletion activity of the TNAP-Cre line it is 
conceivable that in embryos where TNAP-Cre mediated deletion occurred throughout 
the 1CM and/or epiblast these embryos would be lost which may account for the 
fraction of TNAP-Cre Oct-4-"OxP embryos that were not present. Lomeli and colleagues 
did report that the maternal contribution of the TNAP-Cre allele appeared to result in 
an increased incident of mosaic expression for the ZIAP reporter allele and they 
attributed this to a maternal effect; either the presence of TNAP-Cre RNA in the oocyte 
or different specificity of the maternal TNAP-Cre allele (Lomeli et al, 2000). Given the 
consistent early ectopic activity of the TNAP-Cre line observed for both maternal and 
paternal inheritance of the TNAP-Cre allele in this study it was not possible to ascertain 
if this was the same maternal effect they had observed. Furthermore, TNAP-Cre 
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mediated deletion may vary between target loci such that deletion at reporter loci may 
not reflect that at the foxed Oct-4 locus. 
5.2 	Consequences of ZP3-Cre mediated deletion at the foxed Oct-4 locus. 
Activation of dormant reporter lines showed that ZP3-Cre mediated deletion was 
found to be specifically confined to developing oocytes and was detectable in primary 
oocytes onwards. Pups born from ZP3-Cre Oct 	females, that theoretically lacked 
Oct-4 in their oocytes, always inherited the recombined Oct-4 allele in a Mendelian 
fashion. This suggested that recombination at the floxed Oct-4 locus had occurred in 
the oocyte or possibly in the single cell embryo; raising the possibility that Oct-4 is not 
required in oocytes. In mutant animals it was not possible to deduce whether the 
oocytes were actually deficient in Oct-4 protein and given the fact that all oocytes of the 
correct genotype had undergone recombination it was also conceivable that the timing 
of the excision may have occurred post the burst of Oct-4 expression in oocytes as they 
exit meiotic arrest. These results and reasons for late excision and lack of phenotype 
are discussed below. 
For the ZP3-Cre line, both reporter line studies indicated that ZP3-Cre mediated 
deletion occurred in the expected pattern (Lewandoski et al, 1996) and was clearly 
detected in oocytes from the early stages of meiotic arrest onwards coinciding with the 
published expression pattern of ZP3 (Philpott et cii, 1987). Reporter line studies and 
generation of ZP3CreOct4/10x' mice required mixing of genetic backgrounds but no 
apparent ectopic activity of the ZP3-Cre allele was detectable for the reported line 
studies unlike for TNAP-Cre. ZP3-Cre Oct-4-/IoxP mice were fertile, but produced 
smaller than average litter sizes. This can be attributed to the presence of ZP3 -Crc allele 
since heterozygous ZP3-Cre animals tend to have smaller than average litter sizes 
(unpublished observation, B. Knowles). Analysis of genotypes of pups born from ZP3- 
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Cre' Oct-40> female mice showed that the foxed Oct-4 allele where inherited was 
always recombined and this was independent of the inheritance of the ZP3-Cre allele. 
This would indicate that ZP3-Cre mediated recombination at the floxed Oct-4 locus had 
occurred prior to fertilisation or in the one cell embryo but the exact time point during 
oogenesis when deletion had occurred was not known. The reporter line studies 
suggested that ZP3-Cre mediated deletion occurred from the early stages of meiotic 
arrest but as no reporter was activated on recombination at the floxed Oct-4 locus the 
exact timing of recombination at the locus was not known. To attempt to elucidate 
whether Oct-4 protein was present or absent in such oocytes a-Oct-4 antibodies were 
used to stained sectioned or whole oocytes. These experiments were inconclusive; 
furthermore attempts to perform Oct-4 in situ hybridisation on ovary sections and 
whole mount were also unsuccessful. One way of establishing when recombination 
had occurred at the foxed Oct-4 locus would be to use an in situ PCR approach, this 
was not actually attempted. 
Pups born from ZP3-Cre Oct-4" female either inherited an Oct-4-  or Oct4d P 
allele. There appeared to be a discrepancy in the numbers of null alleles versus floxed 
recombined alleles inherited. It was expected this would be in a 1:1 ratio since oocytes 
with null allele are viable in heterozygous mice due to the presence of maternal rnRNA 
from the wildtype Oct-4 allele. Given that recombination at the foxed Oct-4 locus at a 
given time point would result in an oocyte (4N, 2N or iN depending when deletion 
occurred) being null for Oct-4 potentially being lost the sister oocyte that had inherited 
the null allele would be expected to be lost also hence a 1:1 ratio would be obtained (see 
Figures 4.1 and 4.2). The small numbers of pups analysed or PCR errors may account 
for this artifact. It was not possible to deduce whether or not oocytes from ZP3-Cre -
Oct4/l0 ' female mice were null for Oct-4 so it could not be ascertained if the deletion at 
the foxed Oct-4 locus had occurred too late or not i.e. prior to the burst in Oct-4 
expression first occurring in oocytes of approximately 50im in diameter as they exit 
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meiotic arrest. If the deletion had occurred later than expected, residual maternal Oct-
4 rnRNA and/or protein may have been sufficient to carry the oocyte through to 
fertilisation. 
Reasons for late deletion are unclear but one possibility could be due to physical 
masking of the Oct-4 locus during meiotic arrest. Previously it has been shown that in 
vitro extinction of Oct-4 expression is associated with changes in methylation, 
chromatin structure and transcriptional activity in the 5' upstream regulatory region 
(Ben-Shushan. E et al, 1993). More recently Gidekel and colleagues have shown that in 
vivo the Oct-4 gene harbours a cis specific demodification element that includes the PE 
sequence. This element resulted in demethylation in EC cells where the sequence was 
initially methylated and protected the surrounding local region from dc novo 
methylation in post implantation embryos (Gidekel and Bergman, 2002). This element 
provides a mechanism that ensures undermethylation of genes that are required to be 
expressed at a time when de novo methylation is occurring. It has been proposed that 
during oogenesis the PE demethylation element may play a role in protecting the Oct-4 
gene from undergoing de novo methylation at E15.5 thereby allowing its later re-
expression as oocytes exit meiotic arrest. This may be mediated by the binding of 
specific trans-acting factors to the PE element that protect the surrounding sequences 
from global methylation. The extent of binding of such unidentified factors is unclear 
but they could potentially interfere with Crc mediated recombination at the foxed Oct-
4 locus and account for delayed deletion. 
5.3 	Considerations for tissue specific targeted gene inactivation using the Cre-LoxP 
system. 
This project has farther reinforced some of the problems that are becoming more 
apparent with the Cre-LoxP system for tissue specific targeted gene inactivation. As 
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with the TNAP-Cre line expression of Crc recombinase under the control of an 
endogenous promoter does not always reflect the expected expression pattern and this 
can bring about serious complications in phenotype analysis. For instance when the 
germ cell-specific phosphoglycerate kiriase 2 (Pgk2) promoter was used to drive Crc 
expression in spermatocytes and spermatids ectopic expression was detected in other 
tissues during embryogenesis and in non testis tissue in adult mice (Bhullar et cii. 2001). 
Also ectopic expression of Crc was detected in the cartilaginous portions of the ribs 
where Crc expression was directed by the proximal Pax3 promoter which is usually 
restricted to the neural crest (Li et cii. 2000). 
Mosaicism is a critical factor in the majority of tissue specific gene inactivations since 
recombination efficiencies are not 100% (Kwan 2002). As a result deletion of the 
conditional allele in only a subset of target cells occurs creating a situation where the 
wildtype population of cells may potentially obscure and/or mask the inactivation 
phenotype. In order to compensate for this problem the usual approach is to 
trace/distinguish the two cell populations at the cellular level after Crc mediated 
deletion. This can be achieved by using in situ hybridisation and/or immunostaining to 
detect the specific mRNA transcript or protein respectively. A more direct and reliable 
way of circumventing this problem is to incorporate a reporter gene into the floxed 
target gene that is activated upon recombination. However, this is also problematic 
because insertion of exogenous sequences can disrupt regulatory regions of the gene 
and other non related genes which may complicate phenotypic interpretation. 
Relying on an independent reporter line to reflect recombination at the target floxed is 
not always accurate since recombination efficiencies can vary between target loci. For 
instance marked differences in recombination efficiencies for different floxed target 
alleles were found where CreERT  was expressed from the R26R locus in vivo (Vooijs et 
cii, 2001). Difference in target allele activation frequencies may be related to local 
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chromatin structures which may affect accessibility (Muller, 1999). For both TNAP-Cre 
and ZP3-Cre lines both reporter lines gave similar patterns of Crc mediated deletion 
activity. 
As with all targeted mouse mutations the genetic background can play an important 
role in the resultant phenotype (Muller, 1999). For example targeted inactivation of the 
epiderrnal growth factor (EGF) receptor has widely different phenotypic consequences 
depending on the genetic background of the mouse line. Lethality occurs at E7.5 on a 
CF-1 background, midgestation on a 129/Sv background, perinatally on a CD-i 
background and postnatal lethality on a 129ISv x C57BL16 background (Sibilia Ct al. 
1995; Threadgill et al. 1995). No such published examples exist of differences in Crc 
recombinase activity subject to genetic background, but given that the issue of 
background variability in transgenic lines has gained wide spread attention recently it 
should be considered (Muller, 1999). 
5.4 	Conclusions and future perspectives 
The use of the Cre-LoxP system for tissue specific targeted gene inactivation, though 
conceptually straightforward, requires rigorous testing of both the Crc line and floxed 
target allele to avoid complications in phenotypic interpretation. This can be 
circumvented to some extent by incorporating a reporter construct at the foxed target 
locus which is activated upon Cre mediated recombination. The consequences of 
introducing such a cassette into the Oct-4 locus are unknown and if there was any 
disruption in the expression of Oct-4 it would be likely the embryo would be non viable 
due to loss of pluripotency in the 1CM. Failing incorporation of a reporter construct, 
detection of the loss of the protein in those cells that have undergone recombination 
with an appropriate antibody or in situ RNA probe can be carried out. Both of the 
studies here relied on the latter, neither of which gave conclusive results. TNAP-Cre 
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mediated deletion could not be detected in germ cells and this was complicated by the 
fact that early ectopic Crc mediated deletion did occur in the early preimplantation 
embryo. The reasons for this are likely to be due to stochastic differences at the TNAP-
Cre allele compounded by effects of genetic background. ZP3-Cre mediated deletion 
did occur such that all pups born that had inherited the foxed Oct-4 allele had 
undergone recombination. This suggested that recombination at the floxed Oct-4 
locus had occurred in the oocyte or possibly in the single cell embryo. It was not 
possible to elucidate if Oct-4 protein was present in such oocytes. It was also 
conceivable that excision at the Boxed Oct-4 locus had occurred too late, post the burst 
of Oct-4 expression as oocytes exit meiotic arrest and as a result maternal mRNA was 
sufficient to carry the oocyte through to fertilisation. One possible reason for excision 
occurring late could be due to physical masking of the Oct-4 locus during meiotic 
arrest. If this was the case, a Cre-LoxP approach to address the original question of the 
role of the burst of Oct-4 in oocytes as they exit meiotic arrest may not be a viable 
approach. Recently endogenous Oct-4 and c-mos gene were successfully inactivated in 
oocytes using short interfering RNAs (Kim et al. 2002) and this could be another 
approach considered in the future. 
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